{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:34:41Z","timestamp":1787236481264,"version":"build-2736575974"},"reference-count":309,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Health and Medical Research Project (Key Project) of Hunan Provincial Health Commission","award":["20256657"],"award-info":[{"award-number":["20256657"]}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ80223"],"award-info":[{"award-number":["2026JJ80223"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The kynurenine pathway (KP), a crucial route of tryptophan (TRP) catabolism, has emerged as a focal point of investigation because of its complex involvement in regulating central nervous system (CNS) function. This metabolic pathway, which operates in various cell types within the CNS, closely links immune responses, neurotransmission, and neuroinflammation. This review provides an in-depth exploration of the KP, delineating its enzymatic constituents, metabolite profiles, and multifarious roles in sustaining CNS homeostasis, with potential implications for neuropathological conditions including Alzheimer\u2019s disease (AD), Parkinson\u2019s disease (PD), major depressive disorder (MDD), and schizophrenia (SCZ). In addition to the roles of the KP in the pathogenesis of the abovementioned diseases, the related advancements in treatment are discussed.<\/jats:p>","DOI":"10.1515\/revneuro-2025-0130","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:09:47Z","timestamp":1773061787000},"page":"379-408","source":"Crossref","is-referenced-by-count":1,"title":["Physiology of the kynurenine pathway and its implications in CNS disorders"],"prefix":"10.1515","volume":"37","author":[{"given":"Qi","family":"Zhang","sequence":"first","affiliation":[{"name":"Institute of Neuroscience and Department of Physiology, Hengyang Medical School, University of South China , Hengyang , 421001 , Hunan , P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-hui","family":"Tang","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital, Department of Clinical Laboratory Medicine, Hengyang Medical School, University of South China , Hengyang , 421001 , Hunan , P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qing","family":"Tang","sequence":"additional","affiliation":[{"name":"Institute of Neuroscience and Department of Physiology, Hengyang Medical School, University of South China , Hengyang , 421001 , Hunan , P. R. China"},{"name":"The Second Affiliated Hospital, Brain Disease Research Institute of Neurological Medicine Center, Hengyang Medical School, University of South China , Hengyang , 421001 , Hunan , P. R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"2026060415053182102_j_revneuro-2025-0130_ref_001","doi-asserted-by":"crossref","unstructured":"Adler, C.H., Dugger, B.N., Hentz, J.G., Hinni, M.L., Lott, D.G., Driver-Dunckley, E., Mehta, S., Serrano, G., Sue, L.I., Duffy, A., et al.. (2016). Peripheral synucleinopathy in early Parkinson\u2019s disease: submandibular gland needle biopsy findings. Mov. Disord. 31: 250\u2013256, https:\/\/doi.org\/10.1002\/mds.26476.","DOI":"10.1002\/mds.26476"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_002","doi-asserted-by":"crossref","unstructured":"Afia, A.B., Vila, \u00c8., MacDowell, K.S., Ormazabal, A., Leza, J.C., Haro, J.M., Artuch, R., Ramos, B., and Garcia-Bueno, B. (2021). Kynurenine pathway in post-mortem prefrontal cortex and cerebellum in schizophrenia: relationship with monoamines and symptomatology. J.\u00a0Neuroinflammation 18: 198, https:\/\/doi.org\/10.1186\/s12974-021-02260-6.","DOI":"10.1186\/s12974-021-02260-6"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_003","doi-asserted-by":"crossref","unstructured":"Alarcan, H., Chaumond, R., Emond, P., Benz-De Bretagne, I., Lef\u00e8vre, A., Bakkouche, S.E., Veyrat-Durebex, C., Vourc\u2019h, P., Andres, C., Corcia, P., et al. (2021). Some CSF kynurenine pathway intermediates associated with disease evolution in amyotrophic lateral sclerosis. Biomolecules 11: 691, https:\/\/doi.org\/10.3390\/biom11050691.","DOI":"10.3390\/biom11050691"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_004","doi-asserted-by":"crossref","unstructured":"Almulla, A.F., Thipakorn, Y., Vasupanrajit, A., Abo Algon, A.A., Tunvirachaisakul, C., Hashim Aljanabi, A.A., Oxenkrug, G., Al-Hakeim, H.K., and Maes, M. (2022). The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: a systematic review and meta-analysis. Brain Behav. Immun. Health 26: 100537, https:\/\/doi.org\/10.1016\/j.bbih.2022.100537.","DOI":"10.1016\/j.bbih.2022.100537"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_005","doi-asserted-by":"crossref","unstructured":"Amori, L., Wu, H.Q., Marinozzi, M., Pellicciari, R., Guidetti, P., and Schwarcz, R. (2009). Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. Neuroscience 159: 196\u2013203, https:\/\/doi.org\/10.1016\/j.neuroscience.2008.11.055.","DOI":"10.1016\/j.neuroscience.2008.11.055"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_006","doi-asserted-by":"crossref","unstructured":"Andr\u00e9, C., O\u2019Connor, J.C., Kelley, K.W., Lestage, J., Dantzer, R., and Castanon, N. (2008). Spatio-temporal differences in the profile of murine brain expression of proinflammatory cytokines and indoleamine 2,3-dioxygenase in response to peripheral lipopolysaccharide administration. J.\u00a0Neuroimmunol. 200: 90\u201399, https:\/\/doi.org\/10.1016\/j.jneuroim.2008.06.011.","DOI":"10.1016\/j.jneuroim.2008.06.011"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_007","doi-asserted-by":"crossref","unstructured":"Badawy, A.A. and Dougherty, D.M. (2016). Assessment of the Human kynurenine pathway: comparisons and clinical implications of ethnic and gender differences in plasma tryptophan, kynurenine metabolites, and enzyme expressions at baseline and after acute tryptophan loading and depletion. Int. J.\u00a0Tryptophan. Res. 9: 31\u201349, https:\/\/doi.org\/10.4137\/ijtr.s38189.","DOI":"10.4137\/IJTR.S38189"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_008","doi-asserted-by":"crossref","unstructured":"Badawy, A.A., Dawood, S., and Bano, S. (2023). Kynurenine pathway of tryptophan metabolism in pathophysiology and therapy of major depressive disorder. World J.\u00a0Psychiatr. 13: 141\u2013148, https:\/\/doi.org\/10.5498\/wjp.v13.i4.141.","DOI":"10.5498\/wjp.v13.i4.141"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_009","doi-asserted-by":"crossref","unstructured":"Bagasrawala, I., Zecevic, N., and Radonji\u0107, N.V. (2016). N-Methyl D-aspartate receptor antagonist Kynurenic acid affects human cortical development. Front. Neurosci. 10: 435, https:\/\/doi.org\/10.3389\/fnins.2016.00435.","DOI":"10.3389\/fnins.2016.00435"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_010","doi-asserted-by":"crossref","unstructured":"Bakker, L., Ramakers, I., van Boxtel, M.P.J., Schram, M.T., Stehouwer, C.D.A., van der Kallen, C.J.H., Dagnelie, P.C., van Greevenbroek, M.M.J., Wesselius, A., Midttun, \u00d8., et al.. (2021). Associations between plasma kynurenines and cognitive function in individuals with normal glucose metabolism, prediabetes and type 2 diabetes: the maastricht study. Diabetologia 64: 2445\u20132457, https:\/\/doi.org\/10.1007\/s00125-021-05521-4.","DOI":"10.1007\/s00125-021-05521-4"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_011","doi-asserted-by":"crossref","unstructured":"Bakker, L., K\u00f6hler, S., Eussen, S., Choe, K., van den Hove, D.L.A., Kenis, G., Rutten, B.P.F., Ulvik, A., Ueland, P.M., Verhey, F.R.J., et al.. (2023). Correlations between kynurenines in plasma and CSF, and their relation to markers of Alzheimer\u2019s disease pathology. Brain Behav. Immun. 111: 312\u2013319, https:\/\/doi.org\/10.1016\/j.bbi.2023.04.015.","DOI":"10.1016\/j.bbi.2023.04.015"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_012","doi-asserted-by":"crossref","unstructured":"Bansal, T., Alaniz, R.C., Wood, T.K., and Jayaraman, A. (2010). The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation. Proc. Natl. Acad. Sci. USA 107: 228\u2013233, https:\/\/doi.org\/10.1073\/pnas.0906112107.","DOI":"10.1073\/pnas.0906112107"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_013","doi-asserted-by":"crossref","unstructured":"Baran, H., Jellinger, K., and Deecke, L. (1999). Kynurenine metabolism in Alzheimer\u2019s disease. J.\u00a0Neural. Transm. (Vienna) 106: 165\u2013181, https:\/\/doi.org\/10.1007\/s007020050149.","DOI":"10.1007\/s007020050149"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_014","doi-asserted-by":"crossref","unstructured":"Baverel, G., Martin, G., and Michoudet, C. (1990). Glutamine synthesis from aspartate in guinea-pig renal cortex. Biochem. J. 268: 437\u2013442, https:\/\/doi.org\/10.1042\/bj2680437.","DOI":"10.1042\/bj2680437"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_015","doi-asserted-by":"crossref","unstructured":"Beach, T.G., Adler, C.H., Sue, L.I., Vedders, L., Lue, L., White Iii, C.L., Akiyama, H., Caviness, J.N., Shill, H.A., Sabbagh, M.N., et al.. (2010). Multi-organ distribution of phosphorylated alpha-synuclein histopathology in subjects with Lewy body disorders. Acta Neuropathol. 119: 689\u2013702, https:\/\/doi.org\/10.1007\/s00401-010-0664-3.","DOI":"10.1007\/s00401-010-0664-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_016","doi-asserted-by":"crossref","unstructured":"Beal, M.F., Matson, W.R., Storey, E., Milbury, P., Ryan, E.A., Ogawa, T., and Bird, E.D. (1992). Kynurenic acid concentrations are reduced in Huntington\u2019s disease cerebral cortex. J.\u00a0Neurol. Sci. 108: 80\u201387, https:\/\/doi.org\/10.1016\/0022-510x(92)90191-m.","DOI":"10.1016\/0022-510X(92)90191-M"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_017","doi-asserted-by":"crossref","unstructured":"Behan, W.M., McDonald, M., Darlington, L.G., and Stone, T.W. (1999). Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br. J.\u00a0Pharmacol. 128: 1754\u20131760, https:\/\/doi.org\/10.1038\/sj.bjp.0702940.","DOI":"10.1038\/sj.bjp.0702940"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_018","doi-asserted-by":"crossref","unstructured":"Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K.D., et al.. (2011). The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice. Gastroenterology 141: 599\u2013609, 609.e591\u2013593, https:\/\/doi.org\/10.1053\/j.gastro.2011.04.052.","DOI":"10.1053\/j.gastro.2011.04.052"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_019","doi-asserted-by":"crossref","unstructured":"Beutelspacher, S.C., Tan, P.H., McClure, M.O., Larkin, D.F., Lechler, R.I., and George, A.J. (2006). Expression of indoleamine 2,3-dioxygenase (IDO) by endothelial cells: implications for the control of alloresponses. Am. J.\u00a0Transpl. 6: 1320\u20131330, https:\/\/doi.org\/10.1111\/j.1600-6143.2006.01324.x.","DOI":"10.1111\/j.1600-6143.2006.01324.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_020","doi-asserted-by":"crossref","unstructured":"Birch, P.J., Grossman, C.J., and Hayes, A.G. (1988). Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor. Eur. J.\u00a0Pharmacol. 154: 85\u201387, https:\/\/doi.org\/10.1016\/0014-2999(88)90367-6.","DOI":"10.1016\/0014-2999(88)90367-6"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_021","doi-asserted-by":"crossref","unstructured":"Borghammer, P., Horsager, J., Andersen, K., Van Den Berge, N., Raunio, A., Murayama, S., Parkkinen, L., and Myllykangas, L. (2021). Neuropathological evidence of body-first vs. brain-first Lewy body disease. Neurobiol. Dis. 161: 105557, https:\/\/doi.org\/10.1016\/j.nbd.2021.105557.","DOI":"10.1016\/j.nbd.2021.105557"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_022","doi-asserted-by":"crossref","unstructured":"Braidy, N. and Grant, R. (2017). Kynurenine pathway metabolism and neuroinflammatory disease. Neural. Regen. Res. 12: 39\u201342, https:\/\/doi.org\/10.4103\/1673-5374.198971.","DOI":"10.4103\/1673-5374.198971"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_023","doi-asserted-by":"crossref","unstructured":"Braniste, V., Al-Asmakh, M., Kowal, C., Anuar, F., Abbaspour, A., T\u00f3th, M., Korecka, A., Bakocevic, N., Ng, L.G., Kundu, P., et al.. (2014). The gut microbiota influences blood-brain barrier permeability in mice. Sci. Transl. Med. 6: 263ra158, https:\/\/doi.org\/10.1126\/scitranslmed.3009759.","DOI":"10.1126\/scitranslmed.3009759"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_024","doi-asserted-by":"crossref","unstructured":"Breda, C., Sathyasaikumar, K.V., Sograte Idrissi, S., Notarangelo, F.M., Estranero, J.G., Moore, G.G., Green, E.W., Kyriacou, C.P., Schwarcz, R., and Giorgini, F. (2016). Tryptophan-2,3-dioxygenase (TDO) inhibition ameliorates neurodegeneration by modulation of kynurenine pathway metabolites. Proc. Natl. Acad. Sci. USA 113: 5435\u20135440, https:\/\/doi.org\/10.1073\/pnas.1604453113.","DOI":"10.1073\/pnas.1604453113"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_025","doi-asserted-by":"crossref","unstructured":"Brotchie, J.M., Mitchell, I.J., Sambrook, M.A., and Crossman, A.R. (1991). Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primate. Mov. Disord. 6: 133\u2013138, https:\/\/doi.org\/10.1002\/mds.870060208.","DOI":"10.1002\/mds.870060208"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_026","doi-asserted-by":"crossref","unstructured":"Brown, D.G., Soto, R., Yandamuri, S., Stone, C., Dickey, L., Gomes-Neto, J.C., Pastuzyn, E.D., Bell, R., Petersen, C., Buhrke, K., et al.. (2019). The microbiota protects from viral-induced neurologic damage through microglia-intrinsic TLR signaling. eLife 8: e47117, https:\/\/doi.org\/10.7554\/elife.47117.","DOI":"10.7554\/eLife.47117"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_027","doi-asserted-by":"crossref","unstructured":"Brown, S.J., Brown, A.M., Purves-Tyson, T.D., Huang, X.F., Shannon Weickert, C., and Newell, K.A. (2022). Alterations in the kynurenine pathway and excitatory amino acid transporter-2 in depression with and without psychosis: evidence of a potential astrocyte pathology. J.\u00a0Psychiatr. Res. 147: 203\u2013211, https:\/\/doi.org\/10.1016\/j.jpsychires.2021.12.039.","DOI":"10.1016\/j.jpsychires.2021.12.039"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_028","doi-asserted-by":"crossref","unstructured":"Busse, M., Busse, S., Myint, A.M., Gos, T., Dobrowolny, H., M\u00fcller, U.J., Bogerts, B., Bernstein, H.G., and Steiner, J. (2015). Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses? Eur. Arch. Psychiatr. Clin. Neurosci. 265: 321\u2013329, https:\/\/doi.org\/10.1007\/s00406-014-0562-0.","DOI":"10.1007\/s00406-014-0562-0"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_029","doi-asserted-by":"crossref","unstructured":"Calvo-Flores Guzm\u00e1n, B., Elizabeth Chaffey, T., Hansika Palpagama, T., Waters, S., Boix, J., Tate, W.P., Peppercorn, K., Dragunow, M., Waldvogel, H.J., Faull, R.L.M., et al. (2020). The interplay between beta-amyloid 1\u201342 (A\u03b21\u201342)-Induced hippocampal inflammatory response, p-tau, vascular pathology, and their synergistic contributions to neuronal death and behavioral deficits. Front. Mol. Neurosci. 13: 522073, https:\/\/doi.org\/10.3389\/fnmol.2020.552073.","DOI":"10.3389\/fnmol.2020.552073"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_030","doi-asserted-by":"crossref","unstructured":"Campesan, S., Green, E.W., Breda, C., Sathyasaikumar, K.V., Muchowski, P.J., Schwarcz, R., Kyriacou, C.P., and Giorgini, F. (2011). The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington\u2019s disease. Curr. Biol. 21: 961\u2013966, https:\/\/doi.org\/10.1016\/j.cub.2011.04.028.","DOI":"10.1016\/j.cub.2011.04.028"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_031","doi-asserted-by":"crossref","unstructured":"Cannazza, G., Chiarugi, A., Parenti, C., Zanoli, P., and Baraldi, M. (2001). Changes in kynurenic, anthranilic, and quinolinic acid concentrations in rat brain tissue during development. Neurochem. Res. 26: 511\u2013514, https:\/\/doi.org\/10.1023\/A:1010960812204.","DOI":"10.1023\/A:1010960812204"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_032","doi-asserted-by":"crossref","unstructured":"Capece, L., Lewis-Ballester, A., Yeh, S.-R., Estrin, D.A., and Marti, M.A. (2012). Complete reaction mechanism of indoleamine 2,3-dioxygenase as revealed by QM\/MM simulations. J.\u00a0Phys. Chem. B 116: 1401\u20131413, https:\/\/doi.org\/10.1021\/jp2082825.","DOI":"10.1021\/jp2082825"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_033","doi-asserted-by":"crossref","unstructured":"Capuron, L., Neurauter, G., Musselman, D.L., Lawson, D.H., Nemeroff, C.B., Fuchs, D., and Miller, A.H. (2003). Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biol. Psychiatr. 54: 906\u2013914, https:\/\/doi.org\/10.1016\/s0006-3223(03)00173-2.","DOI":"10.1016\/S0006-3223(03)00173-2"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_034","doi-asserted-by":"crossref","unstructured":"Carpenedo, R., Pittaluga, A., Cozzi, A., Attucci, S., Galli, A., Raiteri, M., and Moroni, F. (2001). Presynaptic kynurenate-sensitive receptors inhibit glutamate release. Eur. J.\u00a0Neurosci. 13: 2141\u20132147, https:\/\/doi.org\/10.1046\/j.0953-816x.2001.01592.x.","DOI":"10.1046\/j.0953-816x.2001.01592.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_035","doi-asserted-by":"crossref","unstructured":"Castells-Nobau, A., Fumagalli, A., del Castillo-Izquierdo, \u00c1., Rosell-D\u00edaz, M., de la Vega-Correa, L., Samul\u0117nait\u0117, S., Motger-Albert\u00ed, A., Arnoriaga-Rodr\u00edguez, M., Garre-Olmo, J., Puig, J., et al. (2025). Gut microbial modulation of 3-hydroxyanthranilic acid and dopaminergic signalling influences attention in obesity. Gut, https:\/\/doi.org\/10.1136\/gutjnl-2025-336391.","DOI":"10.1136\/gutjnl-2025-336391"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_036","doi-asserted-by":"crossref","unstructured":"Chang, K.H., Cheng, M.L., Tang, H.Y., Huang, C.Y., Wu, Y.R., and Chen, C.M. (2018). Alternations of metabolic profile and kynurenine metabolism in the plasma of Parkinson\u2019s disease. Mol. Neurobiol. 55: 6319\u20136328, https:\/\/doi.org\/10.1007\/s12035-017-0845-3.","DOI":"10.1007\/s12035-017-0845-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_037","doi-asserted-by":"crossref","unstructured":"Chen, Y., Stankovic, R., Cullen, K.M., Meininger, V., Garner, B., Coggan, S., Grant, R., Brew, B.J., and Guillemin, G.J. (2010). The kynurenine pathway and inflammation in amyotrophic lateral sclerosis. Neurotox Res. 18: 132\u2013142, https:\/\/doi.org\/10.1007\/s12640-009-9129-7.","DOI":"10.1007\/s12640-009-9129-7"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_038","doi-asserted-by":"crossref","unstructured":"Chiarugi, A., Cozzi, A., Ballerini, C., Massacesi, L., and Moroni, F. (2001). Kynurenine 3-mono-oxygenase activity and neurotoxic kynurenine metabolites increase in the spinal cord of rats with experimental allergic encephalomyelitis. Neuroscience 102: 687\u2013695, https:\/\/doi.org\/10.1016\/s0306-4522(00)00504-2.","DOI":"10.1016\/S0306-4522(00)00504-2"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_039","doi-asserted-by":"crossref","unstructured":"Chobot, V., Hadacek, F., Weckwerth, W., and Kubicova, L. (2015). Iron chelation and redox chemistry of anthranilic acid and 3-hydroxyanthranilic acid: a comparison of two structurally related kynurenine pathway metabolites to obtain improved insights into their potential role in neurological disease development. J.\u00a0Organomet. Chem. 782: 103\u2013110, https:\/\/doi.org\/10.1016\/j.jorganchem.2015.01.005.","DOI":"10.1016\/j.jorganchem.2015.01.005"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_040","doi-asserted-by":"crossref","unstructured":"Clark, S.M., Pocivavsek, A., Nicholson, J.D., Notarangelo, F.M., Langenberg, P., McMahon, R.P., Kleinman, J.E., Hyde, T.M., Stiller, J., Postolache, T.T., et al.. (2016). Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals. J.\u00a0Psychiatr. Neurosci. 41: 386\u2013394, https:\/\/doi.org\/10.1503\/jpn.150226.","DOI":"10.1503\/jpn.150226"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_041","doi-asserted-by":"crossref","unstructured":"Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R.D., Shanahan, F., Dinan, T.G., and Cryan, J.F. (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol. Psychiatr. 18: 666\u2013673, https:\/\/doi.org\/10.1038\/mp.2012.77.","DOI":"10.1038\/mp.2012.77"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_042","doi-asserted-by":"crossref","unstructured":"Condray, R., Dougherty, G.G.Jr., Keshavan, M.S., Reddy, R.D., Haas, G.L., Montrose, D.M., Matson, W.R., McEvoy, J., Kaddurah-Daouk, R., and Yao, J.K. (2011). 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia. Int. J.\u00a0Neuropsychopharmacol. 14: 756\u2013767, https:\/\/doi.org\/10.1017\/s1461145710001689.","DOI":"10.1017\/S1461145710001689"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_043","doi-asserted-by":"crossref","unstructured":"Correia, A.S. and Vale, N. (2022). Tryptophan metabolism in depression: a narrative review with a focus on serotonin and kynurenine pathways. Int. J. Mol. Sci. 23: 8493, https:\/\/doi.org\/10.3390\/ijms23158493.","DOI":"10.3390\/ijms23158493"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_044","doi-asserted-by":"crossref","unstructured":"Cs\u00e1ti, A., Edvinsson, L., V\u00e9csei, L., Toldi, J., F\u00fcl\u00f6p, F., Tajti, J., and Warfvinge, K. (2015). Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion. J.\u00a0Headache. Pain 16: 99, https:\/\/doi.org\/10.1186\/s10194-015-0581-x.","DOI":"10.1186\/s10194-015-0581-x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_045","doi-asserted-by":"crossref","unstructured":"Cunningham, C.L., Mart\u00ednez-Cerde\u00f1o, V., and Noctor, S.C. (2013). Microglia regulate the number of neural precursor cells in the developing cerebral cortex. J.\u00a0Neurosci. 33: 4216\u20134233, https:\/\/doi.org\/10.1523\/jneurosci.3441-12.2013.","DOI":"10.1523\/JNEUROSCI.3441-12.2013"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_046","doi-asserted-by":"crossref","unstructured":"da Rocha, A.L., Pinto, A.P., de Sousa Neto, I.V., Mu\u00f1oz, V.R., Marafon, B.B., da Silva, L., Pauli, J.R., Cintra, D.E., Ropelle, E.R., Simabuco, F.M., et al. (2025). Exhaustive exercise abolishes REV-ERB-\u03b1 circadian rhythm and shifts the kynurenine pathway to a neurotoxic profile in mice. J. Physiol. 603: 3923\u20133944, https:\/\/doi.org\/10.1113\/jp288290.","DOI":"10.1113\/JP288290"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_047","doi-asserted-by":"crossref","unstructured":"Dang, Y., Dale, W.E., and Brown, O.R. (2000). Effects of oxygen on kynurenine-3-monooxygenase activity. Redox Rep. 5: 81\u201384, https:\/\/doi.org\/10.1179\/135100000101535564.","DOI":"10.1179\/135100000101535564"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_048","doi-asserted-by":"crossref","unstructured":"Dantzer, R., O\u2019Connor, J.C., Freund, G.G., Johnson, R.W., and Kelley, K.W. (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nat. Rev. Neurosci. 9: 46\u201356, https:\/\/doi.org\/10.1038\/nrn2297.","DOI":"10.1038\/nrn2297"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_049","doi-asserted-by":"crossref","unstructured":"de Carvalho, L.P., Bochet, P., and Rossier, J. (1996). The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem. Int. 28: 445\u2013452, https:\/\/doi.org\/10.1016\/0197-0186(95)00091-7.","DOI":"10.1016\/0197-0186(95)00091-7"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_050","doi-asserted-by":"crossref","unstructured":"Deng, Y., Zhou, M., Wang, J., Yao, J., Yu, J., Liu, W., Wu, L., Wang, J., and Gao, R. (2021). Involvement of the microbiota-gut-brain axis in chronic restraint stress: disturbances of the kynurenine metabolic pathway in both the gut and brain. Gut Microb. 13: 1\u201316, https:\/\/doi.org\/10.1080\/19490976.2020.1869501.","DOI":"10.1080\/19490976.2020.1869501"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_051","doi-asserted-by":"crossref","unstructured":"Diaz Heijtz, R., Wang, S., Anuar, F., Qian, Y., Bj\u00f6rkholm, B., Samuelsson, A., Hibberd, M.L., Forssberg, H., and Pettersson, S. (2011). Normal gut microbiota modulates brain development and behavior. Proc. Natl. Acad. Sci. USA 108: 3047\u20133052, https:\/\/doi.org\/10.1073\/pnas.1010529108.","DOI":"10.1073\/pnas.1010529108"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_052","doi-asserted-by":"crossref","unstructured":"Dobelis, P., Staley, K.J., and Cooper, D.C. (2012). Lack of modulation of nicotinic acetylcholine Alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons. PLoS One 7: e41108, https:\/\/doi.org\/10.1371\/journal.pone.0041108.","DOI":"10.1371\/journal.pone.0041108"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_053","doi-asserted-by":"crossref","unstructured":"Dobrovolsky, V.N., Bowyer, J.F., Pabarcus, M.K., Heflich, R.H., Williams, L.D., Doerge, D.R., Arvidsson, B., Bergquist, J., and Casida, J.E. (2005). Effect of arylformamidase (kynurenine formamidase) gene inactivation in mice on enzymatic activity, kynurenine pathway metabolites and phenotype. Biochim. Biophys. Acta 1724: 163\u2013172, https:\/\/doi.org\/10.1016\/j.bbagen.2005.03.010.","DOI":"10.1016\/j.bbagen.2005.03.010"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_054","doi-asserted-by":"crossref","unstructured":"Dongol, A., Chen, X., Zheng, P., Seyhan, Z.B., and Huang, X.F. (2023). Quinolinic acid impairs mitophagy promoting microglia senescence and poor healthspan in C. elegans: a mechanism of impaired aging process. Biol. Direct 18: 86, https:\/\/doi.org\/10.1186\/s13062-023-00445-y.","DOI":"10.1186\/s13062-023-00445-y"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_055","doi-asserted-by":"crossref","unstructured":"Dugu\u00e9, P.A., Hodge, A.M., Ulvik, A., Ueland, P.M., Midttun, \u00d8., Rinaldi, S., MacInnis, R.J., Li, S.X., Meyer, K., Navionis, A.S., et al. (2022). Association of markers of inflammation, the kynurenine pathway and B vitamins with age and mortality, and a signature of inflammaging. J.\u00a0Gerontol. A Biol. Sci. Med. Sci. 77: 826\u2013836, https:\/\/doi.org\/10.1093\/gerona\/glab163.","DOI":"10.1093\/gerona\/glab163"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_056","doi-asserted-by":"crossref","unstructured":"Eleftheriadis, T., Pissas, G., Filippidis, G., Liakopoulos, V., and Stefanidis, I. (2021). The role of indoleamine 2,3-Dioxygenase in renal tubular epithelial cells senescence under anoxia or reoxygenation. Biomolecules 11: 1522, https:\/\/doi.org\/10.3390\/biom11101522.","DOI":"10.3390\/biom11101522"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_057","doi-asserted-by":"crossref","unstructured":"Erhardt, S., Blennow, K., Nordin, C., Skogh, E., Lindstr\u00f6m, L.H., and Engberg, G. (2001). Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci. Lett. 313: 96\u201398, https:\/\/doi.org\/10.1016\/s0304-3940(01)02242-x.","DOI":"10.1016\/S0304-3940(01)02242-X"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_058","doi-asserted-by":"crossref","unstructured":"Erny, D., Hrab\u011b de Angelis, A.L., Jaitin, D., Wieghofer, P., Staszewski, O., David, E., Keren-Shaul, H., Mahlakoiv, T., Jakobshagen, K., Buch, T., et al.. (2015). Host microbiota constantly control maturation and function of microglia in the CNS. Nat. Neurosci. 18: 965\u2013977, https:\/\/doi.org\/10.1038\/nn.4030.","DOI":"10.1038\/nn.4030"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_059","doi-asserted-by":"crossref","unstructured":"Espey, M.G., Chernyshev, O.N., Reinhard, J.F.Jr., Namboodiri, M.A., and Colton, C.A. (1997). Activated human microglia produce the excitotoxin quinolinic acid. Neuroreport 8: 431\u2013434, https:\/\/doi.org\/10.1097\/00001756-199701200-00011.","DOI":"10.1097\/00001756-199701200-00011"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_060","doi-asserted-by":"crossref","unstructured":"Fallarino, F., Grohmann, U., Vacca, C., Bianchi, R., Orabona, C., Spreca, A., Fioretti, M.C., and Puccetti, P. (2002). T\u00a0cell apoptosis by tryptophan catabolism. Cell Death Differ. 9: 1069\u20131077, https:\/\/doi.org\/10.1038\/sj.cdd.4401073.","DOI":"10.1038\/sj.cdd.4401073"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_061","doi-asserted-by":"crossref","unstructured":"Feng, W., Wang, Y., Liu, Z.Q., Zhang, X., Han, R., Miao, Y.Z., and Qin, Z.H. (2017). Microglia activation contributes to quinolinic acid-induced neuronal excitotoxicity through TNF-\u03b1. Apoptosis 22: 696\u2013709, https:\/\/doi.org\/10.1007\/s10495-017-1363-5.","DOI":"10.1007\/s10495-017-1363-5"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_062","doi-asserted-by":"crossref","unstructured":"Fernandes, A.M., Landeira-Fernandez, A.M., Souza-Santos, P., Carvalho-Alves, P.C., and Castilho, R.F. (2008). Quinolinate-induced rat striatal excitotoxicity impairs endoplasmic reticulum Ca2+-ATPase function. Neurochem. Res. 33: 1749\u20131758, https:\/\/doi.org\/10.1007\/s11064-008-9619-7.","DOI":"10.1007\/s11064-008-9619-7"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_063","doi-asserted-by":"crossref","unstructured":"Fernandes, B.S., Inam, M.E., Enduru, N., Quevedo, J., and Zhao, Z. (2023). The kynurenine pathway in Alzheimer\u2019s disease: a meta-analysis of central and peripheral levels. Braz. J.\u00a0Psychiatr. 45: 286\u2013297, https:\/\/doi.org\/10.47626\/1516-4446-2022-2962.","DOI":"10.47626\/1516-4446-2022-2962"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_064","doi-asserted-by":"crossref","unstructured":"Fertan, E., Stover, K.R.J., Brant, M.G., Stafford, P.M., Kelly, B., Diez-Cecilia, E., Wong, A.A., Weaver, D.F., and Brown, R.E. (2019). Effects of the novel IDO inhibitor DWG-1036 on the behavior of Male and female 3xTg-AD mice. Front. Pharmacol. 10, https:\/\/doi.org\/10.3389\/fphar.2019.01044.","DOI":"10.3389\/fphar.2019.01044"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_065","doi-asserted-by":"crossref","unstructured":"Forsyth, C.B., Shannon, K.M., Kordower, J.H., Voigt, R.M., Shaikh, M., Jaglin, J.A., Estes, J.D., Dodiya, H.B., and Keshavarzian, A. (2011). Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease. PLoS One 6: e28032, https:\/\/doi.org\/10.1371\/journal.pone.0028032.","DOI":"10.1371\/journal.pone.0028032"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_066","doi-asserted-by":"crossref","unstructured":"Foster, A.C., Collins, J.F., and Schwarcz, R. (1983). On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 22: 1331\u20131342, https:\/\/doi.org\/10.1016\/0028-3908(83)90221-6.","DOI":"10.1016\/0028-3908(83)90221-6"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_067","doi-asserted-by":"crossref","unstructured":"Foster, A.C., Vezzani, A., French, E.D., and Schwarcz, R. (1984). Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci. Lett. 48: 273\u2013278, https:\/\/doi.org\/10.1016\/0304-3940(84)90050-8.","DOI":"10.1016\/0304-3940(84)90050-8"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_068","doi-asserted-by":"crossref","unstructured":"Fujikawa, M., Ueda, M., and Maruyama, K. (2024). Role of kynurenine and its derivatives in the neuroimmune system. Int. J.\u00a0Mol. Sci. 25: 7144, https:\/\/doi.org\/10.3390\/ijms25137144.","DOI":"10.3390\/ijms25137144"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_069","doi-asserted-by":"crossref","unstructured":"Fukuda, A., Muramatsu, K., Okabe, A., Shimano, Y., Hida, H., Fujimoto, I., and Nishino, H. (1998). NMDA receptor-mediated differential laminar susceptibility to the intracellular Ca2+ accumulation induced by oxygen-glucose deprivation in rat neocortical slices. J.\u00a0Neurophysiol. 79: 430\u2013438, https:\/\/doi.org\/10.1152\/jn.1998.79.1.430.","DOI":"10.1152\/jn.1998.79.1.430"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_070","doi-asserted-by":"crossref","unstructured":"Fukui, S., Schwarcz, R., Rapoport, S.I., Takada, Y., and Smith, Q.R. (1991). Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism. J.\u00a0Neurochem. 56: 2007\u20132017, https:\/\/doi.org\/10.1111\/j.1471-4159.1991.tb03460.x.","DOI":"10.1111\/j.1471-4159.1991.tb03460.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_071","doi-asserted-by":"crossref","unstructured":"Gao, K., Mu, C.-l., Farzi, A., and Zhu, W.-y. (2020). Tryptophan metabolism: a link between the gut microbiota and brain. Adv. Nutr. 11: 709\u2013723, https:\/\/doi.org\/10.1093\/advances\/nmz127.","DOI":"10.1093\/advances\/nmz127"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_072","doi-asserted-by":"crossref","unstructured":"Garrison, A.M., Parrott, J.M., Tu\u00f1on, A., Delgado, J., Redus, L., and O\u2019Connor, J.C. (2018). Kynurenine pathway metabolic balance influences microglia activity: targeting kynurenine monooxygenase to dampen neuroinflammation. Psychoneuroendocrinology 94: 1\u201310, https:\/\/doi.org\/10.1016\/j.psyneuen.2018.04.019.","DOI":"10.1016\/j.psyneuen.2018.04.019"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_073","doi-asserted-by":"crossref","unstructured":"Ghiboub, M., Boneh, R.S., Sovran, B., Wine, E., Lef\u00e8vre, A., Emond, P., Verburgt, C.M., Benninga, M.A., de Jonge, W.J., and Van Limbergen, J.E. (2023). Sustained diet-induced remission in pediatric Crohn\u2019s Disease is associated with kynurenine and serotonin pathways. Inflamm. Bowel. Dis. 29: 684\u2013694, https:\/\/doi.org\/10.1093\/ibd\/izac262.","DOI":"10.1093\/ibd\/izac262"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_074","doi-asserted-by":"crossref","unstructured":"Gibney, S.M., Fagan, E.M., Waldron, A.-M., O\u2019Byrne, J., Connor, T.J., and Harkin, A. (2014). Inhibition of stress-induced hepatic tryptophan 2,3-dioxygenase exhibits antidepressant activity in an animal model of depressive behaviour. Int. J.\u00a0Neuropsychopharmacol. 17: 917\u2013928, https:\/\/doi.org\/10.1017\/s1461145713001673.","DOI":"10.1017\/S1461145713001673"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_075","doi-asserted-by":"crossref","unstructured":"Giil, L.M., Midttun, \u00d8., Refsum, H., Ulvik, A., Advani, R., Smith, A.D., and Ueland, P.M. (2017). Kynurenine pathway metabolites in Alzheimer\u2019s disease. J.\u00a0Alzheimers Dis. 60: 495\u2013504, https:\/\/doi.org\/10.3233\/jad-170485.","DOI":"10.3233\/JAD-170485"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_076","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-G\u00f3mez, P., P\u00e9rez-Hern\u00e1ndez, M., Guti\u00e9rrez-L\u00f3pez, M.D., Vidal, R., Abuin-Mart\u00ednez, C., O\u2019Shea, E., and Colado, M.I. (2018). Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens. Neuropharmacology 135: 581\u2013591, https:\/\/doi.org\/10.1016\/j.neuropharm.2018.04.016.","DOI":"10.1016\/j.neuropharm.2018.04.016"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_077","doi-asserted-by":"crossref","unstructured":"Gim\u00e9nez-G\u00f3mez, P., P\u00e9rez-Hern\u00e1ndez, M., O\u2019Shea, E., Caso, J.R., Mart\u00edn-Hernandez, D., Cervera, L.A., Centelles, M.L.G., Guti\u00e9rrez-Lopez, M.D., and Colado, M.I. (2019). Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice. Faseb. J. 33: 12900\u201312914, https:\/\/doi.org\/10.1096\/fj.201900491RR.","DOI":"10.1096\/fj.201900491RR"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_078","doi-asserted-by":"crossref","unstructured":"Ginhoux, F., Greter, M., Leboeuf, M., Nandi, S., See, P., Gokhan, S., Mehler, M.F., Conway, S.J., Ng, L.G., Stanley, E.R., et al.. (2010). Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330: 841\u2013845, https:\/\/doi.org\/10.1126\/science.1194637.","DOI":"10.1126\/science.1194637"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_079","doi-asserted-by":"crossref","unstructured":"Giorgini, F., Huang, S.-Y., Sathyasaikumar, K.V., Notarangelo, F.M., Thomas, M.A.R., Tararina, M., Wu, H.-Q., Schwarcz, R., and Muchowski, P.J. (2013). Targeted deletion of kynurenine 3-Monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain. J.\u00a0Biol. Chem. 288: 36554\u201336566, https:\/\/doi.org\/10.1074\/jbc.m113.503813.","DOI":"10.1074\/jbc.M113.503813"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_080","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-S\u00e1nchez, M., Jim\u00e9nez, J., Narv\u00e1ez, A., Antequera, D., Llamas-Velasco, S., Mart\u00edn, A.H.-S., Molina Arjona, J.A., L\u00f3pez de Munain, A., Lle\u00f3 Bisa, A., Marco, M.-P., et al. (2020). Kynurenic acid levels are increased in the CSF of Alzheimer\u2019s disease patients. Biomolecules 10: 571, https:\/\/doi.org\/10.3390\/biom10040571.","DOI":"10.3390\/biom10040571"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_081","doi-asserted-by":"crossref","unstructured":"Graham, W.C., Robertson, R.G., Sambrook, M.A., and Crossman, A.R. (1990). Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism. Life Sci. 47: PL91\u2013PL97, https:\/\/doi.org\/10.1016\/0024-3205(90)90376-3.","DOI":"10.1016\/0024-3205(90)90376-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_082","doi-asserted-by":"crossref","unstructured":"Guidetti, P., Okuno, E., and Schwarcz, R. (1997). Characterization of rat brain kynurenine aminotransferases I and II. J.\u00a0Neurosci. Res. 50: 457\u2013465, https:\/\/doi.org\/10.1002\/(SICI)1097-4547(19971101)50:3<457::AID-JNR12=3.0.CO;2-3.","DOI":"10.1002\/(SICI)1097-4547(19971101)50:3<457::AID-JNR12>3.0.CO;2-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_083","doi-asserted-by":"crossref","unstructured":"Guidetti, P., Bates, G.P., Graham, R.K., Hayden, M.R., Leavitt, B.R., MacDonald, M.E., Slow, E.J., Wheeler, V.C., Woodman, B., and Schwarcz, R. (2006). Elevated brain 3-hydroxykynurenine and quinolinate levels in Huntington disease mice. Neurobiol. Dis. 23: 190\u2013197, https:\/\/doi.org\/10.1016\/j.nbd.2006.02.011.","DOI":"10.1016\/j.nbd.2006.02.011"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_084","doi-asserted-by":"crossref","unstructured":"Guidetti, P., Hoffman, G.E., Melendez-Ferro, M., Albuquerque, E.X., and Schwarcz, R. (2007). Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry. Glia 55: 78\u201392, https:\/\/doi.org\/10.1002\/glia.20432.","DOI":"10.1002\/glia.20432"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_085","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J., Kerr, S.J., Smythe, G.A., Smith, D.G., Kapoor, V., Armati, P.J., Croitoru, J., and Brew, B.J. (2001). Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection. J.\u00a0Neurochem. 78: 842\u2013853, https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00498.x.","DOI":"10.1046\/j.1471-4159.2001.00498.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_086","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J., Smith, D.G., Smythe, G.A., Armati, P.J., and Brew, B.J. (2003a). Expression of the kynurenine pathway enzymes in human microglia and macrophages. Adv. Exp. Med. Biol. 527: 105\u2013112, https:\/\/doi.org\/10.1007\/978-1-4615-0135-0_12.","DOI":"10.1007\/978-1-4615-0135-0_12"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_087","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J., Smythe, G.A., Veas, L.A., Takikawa, O., and Brew, B.J. (2003b). A beta 1\u201342 induces production of quinolinic acid by human macrophages and microglia. Neuroreport 14: 2311\u20132315, https:\/\/doi.org\/10.1097\/00001756-200312190-00005.","DOI":"10.1097\/00001756-200312190-00005"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_088","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J., Brew, B.J., Noonan, C.E., Takikawa, O., and Cullen, K.M. (2005a). Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer\u2019s disease hippocampus. Neuropathol. Appl. Neurobiol. 31: 395\u2013404, https:\/\/doi.org\/10.1111\/j.1365-2990.2005.00655.x.","DOI":"10.1111\/j.1365-2990.2005.00655.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_089","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J., Smythe, G., Takikawa, O., and Brew, B.J. (2005b). Expression of indoleamine 2,3-dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons. Glia 49: 15\u201323, https:\/\/doi.org\/10.1002\/glia.20090.","DOI":"10.1002\/glia.20090"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_090","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J., Wang, L., and Brew, B.J. (2005c). Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J.\u00a0Neuroinflammation 2: 16, https:\/\/doi.org\/10.1186\/1742-2094-2-16.","DOI":"10.1186\/1742-2094-2-16"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_091","doi-asserted-by":"crossref","unstructured":"Guillemin, G.J. (2012). Quinolinic acid, the inescapable neurotoxin. Febs. J. 279: 1356\u20131365, https:\/\/doi.org\/10.1111\/j.1742-4658.2012.08485.x.","DOI":"10.1111\/j.1742-4658.2012.08485.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_092","doi-asserted-by":"crossref","unstructured":"Gulaj, E., Pawlak, K., Bien, B., and Pawlak, D. (2010). Kynurenine and its metabolites in Alzheimer\u2019s disease patients. Adv. Med. Sci. 55: 204\u2013211, https:\/\/doi.org\/10.2478\/v10039-010-0023-6.","DOI":"10.2478\/v10039-010-0023-6"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_093","doi-asserted-by":"crossref","unstructured":"Guloksuz, S., Wichers, M., Kenis, G., Russel, M.G., Wauters, A., Verkerk, R., Arts, B., and van Os, J. (2013). Depressive symptoms in Crohn\u2019s disease: relationship with immune activation and tryptophan availability. PLoS One 8: e60435, https:\/\/doi.org\/10.1371\/journal.pone.0060435.","DOI":"10.1371\/journal.pone.0060435"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_094","doi-asserted-by":"crossref","unstructured":"Guo, J., Williams, D.J., Puhl, H.L.3rd, and Ikeda, S.R. (2008). Inhibition of N-type calcium channels by activation of GPR35, an orphan receptor, heterologously expressed in rat sympathetic neurons. J.\u00a0Pharmacol. Exp. Ther. 324: 342-351, https:\/\/doi.org\/10.1124\/jpet.107.127266.","DOI":"10.1124\/jpet.107.127266"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_095","doi-asserted-by":"crossref","unstructured":"Gupta, N.K., Thaker, A.I., Kanuri, N., Riehl, T.E., Rowley, C.W., Stenson, W.F., and Ciorba, M.A. (2012). Serum analysis of tryptophan catabolism pathway: correlation with Crohn\u2019s disease activity. Inflamm. Bowel. Dis. 18: 1214\u20131220, https:\/\/doi.org\/10.1002\/ibd.21849.","DOI":"10.1002\/ibd.21849"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_096","doi-asserted-by":"crossref","unstructured":"Hammond, S.L., Bantle, C.M., Popichak, K.A., Wright, K.A., Thompson, D., Forero, C., Kirkley, K.S., Damale, P.U., Chong, E.K.P., and Tjalkens, R.B. (2020). NF-\u03baB signaling in astrocytes modulates brain inflammation and neuronal injury following sequential exposure to manganese and MPTP during development and aging. Toxicol. Sci. 177: 506\u2013520, https:\/\/doi.org\/10.1093\/toxsci\/kfaa115.","DOI":"10.1093\/toxsci\/kfaa115"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_097","doi-asserted-by":"crossref","unstructured":"Haq, S., Grondin, J.A., and Khan, W.I. (2021). Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation. Faseb. J. 35: e21888, https:\/\/doi.org\/10.1096\/fj.202100702r.","DOI":"10.1096\/fj.202100702R"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_098","doi-asserted-by":"crossref","unstructured":"Hartai, Z., Klivenyi, P., Janaky, T., Penke, B., Dux, L., and Vecsei, L. (2005). Kynurenine metabolism in plasma and in red blood cells in Parkinson\u2019s disease. J.\u00a0Neurol. Sci. 239: 31\u201335, https:\/\/doi.org\/10.1016\/j.jns.2005.07.006.","DOI":"10.1016\/j.jns.2005.07.006"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_099","doi-asserted-by":"crossref","unstructured":"Hartstra, A.V., Sch\u00fcppel, V., Imangaliyev, S., Schrantee, A., Prodan, A., Collard, D., Levin, E., Dallinga-Thie, G., Ackermans, M.T., Winkelmeijer, M., et al.. (2020). Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Mol. Metab. 42: 101076, https:\/\/doi.org\/10.1016\/j.molmet.2020.101076.","DOI":"10.1016\/j.molmet.2020.101076"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_100","doi-asserted-by":"crossref","unstructured":"Havelund, J.F., Andersen, A.D., Binzer, M., Blaabjerg, M., Heegaard, N.H.H., Stenager, E., Faergeman, N.J., and Gramsbergen, J.B. (2017). Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia. J.\u00a0Neurochem. 142: 756\u2013766, https:\/\/doi.org\/10.1111\/jnc.14104.","DOI":"10.1111\/jnc.14104"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_101","doi-asserted-by":"crossref","unstructured":"Heilman, P.L., Wang, E.W., Lewis, M.M., Krzyzanowski, S., Capan, C.D., Burmeister, A.R., Du, G., Escobar Galvis, M.L., Brundin, P., Huang, X., et al.. (2020). Tryptophan metabolites are associated with symptoms and nigral pathology in Parkinson\u2019s Disease. Mov. Disord. 35: 2028\u20132037, https:\/\/doi.org\/10.1002\/mds.28202.","DOI":"10.1002\/mds.28202"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_102","doi-asserted-by":"crossref","unstructured":"Henkel, J.S., Engelhardt, J.I., Sikl\u00f3s, L., Simpson, E.P., Kim, S.H., Pan, T., Goodman, J.C., Siddique, T., Beers, D.R., and Appel, S.H. (2004). Presence of dendritic cells, MCP-1, and activated microglia\/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann. Neurol. 55: 221\u2013235, https:\/\/doi.org\/10.1002\/ana.10805.","DOI":"10.1002\/ana.10805"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_103","doi-asserted-by":"crossref","unstructured":"Heyes, M.P., Brew, B.J., Martin, A., Price, R.W., Salazar, A.M., Sidtis, J.J., Yergey, J.A., Mouradian, M.M., Sadler, A.E., Keilp, J., et al.. (1991). Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status. Ann. Neurol. 29: 202\u2013209, https:\/\/doi.org\/10.1002\/ana.410290215.","DOI":"10.1002\/ana.410290215"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_104","doi-asserted-by":"crossref","unstructured":"Heylen, A., Vermeiren, Y., Kema, I.P., van Faassen, M., van der Ley, C., Van Dam, D., and De Deyn, P.P. (2023). Brain kynurenine pathway metabolite levels may reflect extent of neuroinflammation in ALS, FTD and early onset AD. Pharmaceuticals 16: 615, https:\/\/doi.org\/10.3390\/ph16040615.","DOI":"10.3390\/ph16040615"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_105","doi-asserted-by":"crossref","unstructured":"Hickman, S.E., Kingery, N.D., Ohsumi, T.K., Borowsky, M.L., Wang, L.C., Means, T.K., and El Khoury, J. (2013). The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 16: 1896\u20131905, https:\/\/doi.org\/10.1038\/nn.3554.","DOI":"10.1038\/nn.3554"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_106","doi-asserted-by":"crossref","unstructured":"Hilmas, C., Pereira, E.F., Alkondon, M., Rassoulpour, A., Schwarcz, R., and Albuquerque, E.X. (2001). The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications. J.\u00a0Neurosci. 21: 7463\u20137473, https:\/\/doi.org\/10.1523\/jneurosci.21-19-07463.2001.","DOI":"10.1523\/JNEUROSCI.21-19-07463.2001"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_107","doi-asserted-by":"crossref","unstructured":"Hochstrasser, T., Ullrich, C., Sperner-Unterweger, B., and Humpel, C. (2011). Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices. Neuroscience 184: 128\u2013138, https:\/\/doi.org\/10.1016\/j.neuroscience.2011.03.070.","DOI":"10.1016\/j.neuroscience.2011.03.070"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_108","doi-asserted-by":"crossref","unstructured":"Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Bj\u00f6rklund, T., Wang, Z.Y., Roybon, L., Melki, R., and Li, J.Y. (2014). Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta. Neuropathol. 128: 805\u2013820, https:\/\/doi.org\/10.1007\/s00401-014-1343-6.","DOI":"10.1007\/s00401-014-1343-6"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_109","doi-asserted-by":"crossref","unstructured":"Hosoi, R., Fujii, Y., Hiroyuki, O., Shukuri, M., Nishiyama, S., Kanazawa, M., Todoroki, K., Arano, Y., Sakai, T., Tsukada, H., et al.. (2021). Evaluation of intracellular processes in quinolinic acid-induced brain damage by imaging reactive oxygen species generation and mitochondrial complex I activity. EJNMMI Res. 11: 99, https:\/\/doi.org\/10.1186\/s13550-021-00841-3.","DOI":"10.1186\/s13550-021-00841-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_110","doi-asserted-by":"crossref","unstructured":"Huang, M., Long, A., Hao, L., Shi, Z., and Zhang, M. (2025). Astrocyte in neurological disease: pathogenesis and therapy. MedComm (2020) 6: e70299, https:\/\/doi.org\/10.1002\/mco2.70299.","DOI":"10.1002\/mco2.70299"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_111","doi-asserted-by":"crossref","unstructured":"Hunt, P.W., Sinclair, E., Rodriguez, B., Shive, C., Clagett, B., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J.N., et al.. (2014). Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection. J.\u00a0Infect. Dis. 210: 1228\u20131238, https:\/\/doi.org\/10.1093\/infdis\/jiu238.","DOI":"10.1093\/infdis\/jiu238"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_112","doi-asserted-by":"crossref","unstructured":"Hunt, C., Macedo, E.C.T., Suchting, R., de Dios, C., Cuellar Leal, V.A., Soares, J.C., Dantzer, R., Teixeira, A.L., and Selvaraj, S. (2020). Effect of immune activation on the kynurenine pathway and depression symptoms\u00a0\u2013\u00a0a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 118: 514\u2013523, https:\/\/doi.org\/10.1016\/j.neubiorev.2020.08.010.","DOI":"10.1016\/j.neubiorev.2020.08.010"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_113","doi-asserted-by":"crossref","unstructured":"Itagaki, S., McGeer, P.L., Akiyama, H., Zhu, S., and Selkoe, D. (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J.\u00a0Neuroimmunol. 24: 173\u2013182, https:\/\/doi.org\/10.1016\/0165-5728(89)90115-x.","DOI":"10.1016\/0165-5728(89)90115-X"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_114","doi-asserted-by":"crossref","unstructured":"Jacobs, K.R., Lim, C.K., Blennow, K., Zetterberg, H., Chatterjee, P., Martins, R.N., Brew, B.J., Guillemin, G.J., and Lovejoy, D.B. (2019). Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer\u2019s disease and relationship to amyloid-\u03b2 and tau. Neurobiol. Aging 80: 11\u201320, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2019.03.015.","DOI":"10.1016\/j.neurobiolaging.2019.03.015"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_115","doi-asserted-by":"crossref","unstructured":"Jana, M., Palencia, C.A., and Pahan, K. (2008). Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer\u2019s disease. J.\u00a0Immunol. 181: 7254\u20137262, https:\/\/doi.org\/10.4049\/jimmunol.181.10.7254.","DOI":"10.4049\/jimmunol.181.10.7254"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_116","doi-asserted-by":"crossref","unstructured":"Janssens, J., Vermeiren, Y., van Faassen, M., van der Ley, C., Kema, I.P., and De Deyn, P.P. (2020). Monoaminergic and kynurenergic characterization of frontotemporal dementia and amyotrophic lateral sclerosis in cerebrospinal fluid and serum. Neurochem. Res. 45: 1191\u20131201, https:\/\/doi.org\/10.1007\/s11064-020-03002-5.","DOI":"10.1007\/s11064-020-03002-5"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_117","doi-asserted-by":"crossref","unstructured":"Jiang, T., Tan, L., Zhu, X.C., Zhang, Q.Q., Cao, L., Tan, M.S., Gu, L.Z., Wang, H.F., Ding, Z.Z., Zhang, Y.D., et al.. (2014). Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer\u2019s disease. Neuropsychopharmacology 39: 2949\u20132962, https:\/\/doi.org\/10.1038\/npp.2014.164.","DOI":"10.1038\/npp.2014.164"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_118","doi-asserted-by":"crossref","unstructured":"Johansson, A.S., Owe-Larsson, B., Asp, L., Kocki, T., Adler, M., Hetta, J., Gardner, R., Lundkvist, G.B., Urbanska, E.M., and Karlsson, H. (2013). Activation of kynurenine pathway in ex\u00a0vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. J.\u00a0Psychiatr. Res. 47: 1815\u20131823, https:\/\/doi.org\/10.1016\/j.jpsychires.2013.08.008.","DOI":"10.1016\/j.jpsychires.2013.08.008"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_119","doi-asserted-by":"crossref","unstructured":"Jones, S.P., Franco, N.F., Varney, B., Sundaram, G., Brown, D.A., de Bie, J., Lim, C.K., Guillemin, G.J., and Brew, B.J. (2015). Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease. PLoS One 10: e0131389, https:\/\/doi.org\/10.1371\/journal.pone.0131389.","DOI":"10.1371\/journal.pone.0131389"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_120","doi-asserted-by":"crossref","unstructured":"Jong Huat, T., Camats-Perna, J., Newcombe, E.A., Onraet, T., Campbell, D., Sucic, J.T., Martini, A., Forner, S., Mirzaei, M., Poon, W., et al.. (2024). The impact of astrocytic NF-\u03baB on healthy and Alzheimer\u2019s disease brains. Sci. Rep. 14: 14305, https:\/\/doi.org\/10.1038\/s41598-024-65248-1.","DOI":"10.1038\/s41598-024-65248-1"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_121","doi-asserted-by":"crossref","unstructured":"Kaindl, A.M., Degos, V., Peineau, S., Gouadon, E., Chhor, V., Loron, G., Le Charpentier, T., Josserand, J., Ali, C., Vivien, D., et al.. (2012). Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann. Neurol. 72: 536\u2013549, https:\/\/doi.org\/10.1002\/ana.23626.","DOI":"10.1002\/ana.23626"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_122","doi-asserted-by":"crossref","unstructured":"Kamphuis, W., Middeldorp, J., Kooijman, L., Sluijs, J.A., Kooi, E.J., Moeton, M., Freriks, M., Mizee, M.R., and Hol, E.M. (2014). Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer\u2019s disease. Neurobiol. Aging 35: 492\u2013510, https:\/\/doi.org\/10.1016\/j.neurobiolaging.2013.09.035.","DOI":"10.1016\/j.neurobiolaging.2013.09.035"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_123","doi-asserted-by":"crossref","unstructured":"Kanai, M., Funakoshi, H., Takahashi, H., Hayakawa, T., Mizuno, S., Matsumoto, K., and Nakamura, T. (2009). Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol. Brain 2: 8, https:\/\/doi.org\/10.1186\/1756-6606-2-8.","DOI":"10.1186\/1756-6606-2-8"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_124","doi-asserted-by":"crossref","unstructured":"Kazemi, A., Noorbala, A.A., Azam, K., Eskandari, M.H., and Djafarian, K. (2019). Effect of probiotic and prebiotic vs placebo on psychological outcomes in patients with major depressive disorder: a randomized clinical trial. Clin. Nutr. 38: 522\u2013528, https:\/\/doi.org\/10.1016\/j.clnu.2018.04.010.","DOI":"10.1016\/j.clnu.2018.04.010"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_125","doi-asserted-by":"crossref","unstructured":"Kegel, M.E., Bhat, M., Skogh, E., Samuelsson, M., Lundberg, K., Dahl, M.L., Sellgren, C., Schwieler, L., Engberg, G., Schuppe-Koistinen, I., et al.. (2014). Imbalanced kynurenine pathway in schizophrenia. Int. J.\u00a0Tryptophan. Res. 7: 15\u201322, https:\/\/doi.org\/10.4137\/ijtr.s16800.","DOI":"10.4137\/IJTR.S16800"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_126","doi-asserted-by":"crossref","unstructured":"Keilhoff, G. and Wolf, G. (1992). Memantine prevents quinolinic acid-induced hippocampal damage. Eur. J.\u00a0Pharmacol. 219: 451\u2013454, https:\/\/doi.org\/10.1016\/0014-2999(92)90487-o.","DOI":"10.1016\/0014-2999(92)90487-O"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_127","doi-asserted-by":"crossref","unstructured":"Kennedy, P.J., Cryan, J.F., Dinan, T.G., and Clarke, G. (2017). Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology 112: 399\u2013412, https:\/\/doi.org\/10.1016\/j.neuropharm.2016.07.002.","DOI":"10.1016\/j.neuropharm.2016.07.002"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_128","doi-asserted-by":"crossref","unstructured":"Kepplinger, B., Baran, H., Sedlnitzky-Semler, B., Badawi, N.R., and Erhart, H. (2011). Stochastic resonance activity influences serum tryptophan metabolism in healthy human subjects. Int. J.\u00a0Tryptophan. Res. 4: 49\u201360, https:\/\/doi.org\/10.4137\/ijtr.s7986.","DOI":"10.4137\/IJTR.S7986"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_129","doi-asserted-by":"crossref","unstructured":"Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T.K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al.. (2017). A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169: 1276\u20131290.e1217, https:\/\/doi.org\/10.1016\/j.cell.2017.05.018.","DOI":"10.1016\/j.cell.2017.05.018"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_130","doi-asserted-by":"crossref","unstructured":"Kesarwani, P., Kant, S., Zhao, Y., Prabhu, A., Buelow, K.L., Miller, C.R., and Chinnaiyan, P. (2023). Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR\/PPAR\u03b3 signaling axis. Nat. Commun. 14: 1459, https:\/\/doi.org\/10.1038\/s41467-023-37170-z.","DOI":"10.1038\/s41467-023-37170-z"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_131","doi-asserted-by":"crossref","unstructured":"Kessler, M., Terramani, T., Lynch, G., and Baudry, M. (1989). A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists. J.\u00a0Neurochem. 52: 1319\u20131328, https:\/\/doi.org\/10.1111\/j.1471-4159.1989.tb01881.x.","DOI":"10.1111\/j.1471-4159.1989.tb01881.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_132","doi-asserted-by":"crossref","unstructured":"Khademi, F., Tutunchi, H., Vaghef-Mehrabani, E., and Ebrahimi-Mameghani, M. (2024). The effect of prebiotic supplementation on serum levels of tryptophan and kynurenine in obese women with major depressive disorder: a double-blinded placebo-controlled randomized clinical trial. BMC Res. Notes 17: 316, https:\/\/doi.org\/10.1186\/s13104-024-06963-w.","DOI":"10.1186\/s13104-024-06963-w"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_133","doi-asserted-by":"crossref","unstructured":"Kim, H., Chen, L., Lim, G., Sung, B., Wang, S., McCabe, M.F., Rusanescu, G., Yang, L., Tian, Y., and Mao, J. (2012). Brain indoleamine 2,3-dioxygenase contributes to the comorbidity of pain and depression. J.\u00a0Clin. Invest. 122: 2940\u20132954, https:\/\/doi.org\/10.1172\/jci61884.","DOI":"10.1172\/JCI61884"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_134","doi-asserted-by":"crossref","unstructured":"Kitt, T.M. and Spector, R. (1987). Transport of quinolinic acid into rabbit and rat brain. Neurochem. Res. 12: 625\u2013628, https:\/\/doi.org\/10.1007\/bf00971011.","DOI":"10.1007\/BF00971011"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_135","doi-asserted-by":"crossref","unstructured":"Knapskog, A.B., Aksnes, M., Edwin, T.H., Ueland, P.M., Ulvik, A., Fang, E.F., Eldholm, R.S., Halaas, N.B., Saltvedt, I., Giil, L.M., et al.. (2023). Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer\u2019s disease. Alzheimers Dement 19: 5573\u20135582, https:\/\/doi.org\/10.1002\/alz.13162.","DOI":"10.1002\/alz.13162"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_136","doi-asserted-by":"crossref","unstructured":"Knyih\u00e1r-Csillik, E., Csillik, B., P\u00e1k\u00e1ski, M., Krisztin-P\u00e9va, B., Dob\u00f3, E., Okuno, E., and V\u00e9csei, L. (2004). Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Neuroscience 126: 899\u2013914, https:\/\/doi.org\/10.1016\/j.neuroscience.2004.04.043.","DOI":"10.1016\/j.neuroscience.2004.04.043"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_137","doi-asserted-by":"crossref","unstructured":"Knyih\u00e1r-Csillik, E., Chadaide, Z., Mih\u00e1ly, A., Krisztin-P\u00e9va, B., Fenyo, R., and V\u00e9csei, L. (2006). Effect of 6-hydroxydopamine treatment on kynurenine aminotransferase-I (KAT-I) immunoreactivity of neurons and glial cells in the rat substantia nigra. Acta Neuropathol. 112: 127\u2013137, https:\/\/doi.org\/10.1007\/s00401-006-0086-4.","DOI":"10.1007\/s00401-006-0086-4"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_138","doi-asserted-by":"crossref","unstructured":"Konradsson-Geuken, A., Wu, H.Q., Gash, C.R., Alexander, K.S., Campbell, A., Sozeri, Y., Pellicciari, R., Schwarcz, R., and Bruno, J.P. (2010). Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry. Neuroscience 169: 1848\u20131859, https:\/\/doi.org\/10.1016\/j.neuroscience.2010.05.052.","DOI":"10.1016\/j.neuroscience.2010.05.052"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_139","doi-asserted-by":"crossref","unstructured":"Koo, Y.S., Kim, H., Park, J.H., Kim, M.J., Shin, Y.I., Choi, B.T., Lee, S.Y., and Shin, H.K. (2018). Indoleamine 2,3-Dioxygenase-Dependent neurotoxic kynurenine metabolism contributes to poststroke depression induced in mice by ischemic stroke along with spatial restraint stress. Oxid Med. Cell Longev. 2018: 2413841, https:\/\/doi.org\/10.1155\/2018\/2413841.","DOI":"10.1155\/2018\/2413841"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_140","doi-asserted-by":"crossref","unstructured":"Kozak, R., Campbell, B.M., Strick, C.A., Horner, W., Hoffmann, W.E., Kiss, T., Chapin, D.S., McGinnis, D., Abbott, A.L., Roberts, B.M., et al.. (2014). Reduction of brain kynurenic acid improves cognitive function. J.\u00a0Neurosci. 34: 10592\u201310602, https:\/\/doi.org\/10.1523\/jneurosci.1107-14.2014.","DOI":"10.1523\/JNEUROSCI.1107-14.2014"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_141","doi-asserted-by":"crossref","unstructured":"Krause, D., Myint, A.M., Schuett, C., Musil, R., Dehning, S., Cerovecki, A., Riedel, M., Arolt, V., Schwarz, M.J., and M\u00fcller, N. (2017). High kynurenine (a Tryptophan metabolite) predicts remission in patients with major depression to add-on treatment with celecoxib. Front. Psychiatr. 8: 16, https:\/\/doi.org\/10.3389\/fpsyt.2017.00016.","DOI":"10.3389\/fpsyt.2017.00016"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_142","doi-asserted-by":"crossref","unstructured":"Kutzing, M.K., Luo, V., and Firestein, B.L. (2012). Protection from glutamate-induced excitotoxicity by memantine. Ann. Biomed. Eng. 40: 1170\u20131181, https:\/\/doi.org\/10.1007\/s10439-011-0494-z.","DOI":"10.1007\/s10439-011-0494-z"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_143","doi-asserted-by":"crossref","unstructured":"Lalitsuradej, E., Sirilun, S., Sittiprapaporn, P., Sivamaruthi, B.S., Pintha, K., Tantipaiboonwong, P., Khongtan, S., Fukngoen, P., Peerajan, S., and Chaiyasut, C. (2022). The effects of synbiotics administration on stress-related parameters in Thai subjects\u00a0\u2013\u00a0a preliminary study. Foods 11: 759, https:\/\/doi.org\/10.3390\/foods11050759.","DOI":"10.3390\/foods11050759"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_144","doi-asserted-by":"crossref","unstructured":"Lebouvier, T., Neunlist, M., Bruley des Varannes, S., Coron, E., Drouard, A., N\u2019Guyen, J.M., Chaumette, T., Tasselli, M., Paillusson, S., Flamand, M., et al.. (2010). Colonic biopsies to assess the neuropathology of Parkinson\u2019s disease and its relationship with symptoms. PLoS One 5: e12728, https:\/\/doi.org\/10.1371\/journal.pone.0012728.","DOI":"10.1371\/journal.pone.0012728"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_145","doi-asserted-by":"crossref","unstructured":"Lee, C.Y.D., Daggett, A., Gu, X., Jiang, L.-L., Langfelder, P., Li, X., Wang, N., Zhao, Y., Park, C.S., Cooper, Y., et al.. (2018). Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in alzheimer\u2019s disease models. Neuron 97: 1032\u20131048.e1035, https:\/\/doi.org\/10.1016\/j.neuron.2018.02.002.","DOI":"10.1016\/j.neuron.2018.02.002"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_146","doi-asserted-by":"crossref","unstructured":"Lekieffre, D., Plotkine, M., Allix, M., and Boulu, R.G. (1990). Kynurenic acid antagonizes hippocampal quinolinic acid neurotoxicity: behavioral and histological evaluation. Neurosci. Lett. 120: 31\u201333, https:\/\/doi.org\/10.1016\/0304-3940(90)90160-b.","DOI":"10.1016\/0304-3940(90)90160-B"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_147","doi-asserted-by":"crossref","unstructured":"Liang, Y., Xie, S., He, Y., Xu, M., Qiao, X., Zhu, Y., and Wu, W. (2022). Kynurenine pathway metabolites as biomarkers in Alzheimer\u2019s disease. Dis. Markers 2022: 9484217, https:\/\/doi.org\/10.1155\/2022\/9484217.","DOI":"10.1155\/2022\/9484217"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_148","doi-asserted-by":"crossref","unstructured":"Liddelow, S.A., Guttenplan, K.A., Clarke, L.E., Bennett, F.C., Bohlen, C.J., Schirmer, L., Bennett, M.L., M\u00fcnch, A.E., Chung, W.S., Peterson, T.C., et al.. (2017). Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541: 481\u2013487, https:\/\/doi.org\/10.1038\/nature21029.","DOI":"10.1038\/nature21029"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_149","doi-asserted-by":"crossref","unstructured":"Lim, C.K., Bilgin, A., Lovejoy, D.B., Tan, V., Bustamante, S., Taylor, B.V., Bessede, A., Brew, B.J., and Guillemin, G.J. (2017). Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression. Sci. Rep. 7: 41473, https:\/\/doi.org\/10.1038\/srep41473.","DOI":"10.1038\/srep41473"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_150","doi-asserted-by":"crossref","unstructured":"Linderholm, K.R., Skogh, E., Olsson, S.K., Dahl, M.L., Holtze, M., Engberg, G., Samuelsson, M., and Erhardt, S. (2012). Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr. Bull. 38: 426\u2013432, https:\/\/doi.org\/10.1093\/schbul\/sbq086.","DOI":"10.1093\/schbul\/sbq086"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_151","doi-asserted-by":"crossref","unstructured":"Linderholm, K.R., Alm, M.T., Larsson, M.K., Olsson, S.K., Goiny, M., Hajos, M., Erhardt, S., and Engberg, G. (2016). Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons. Neuropharmacology 102: 42\u201347, https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.028.","DOI":"10.1016\/j.neuropharm.2015.10.028"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_152","doi-asserted-by":"crossref","unstructured":"Liu, H., Ding, L., Zhang, H., Mellor, D., Wu, H., Zhao, D., Wu, C., Lin, Z., Yuan, J., and Peng, D. (2018). The metabolic factor Kynurenic acid of Kynurenine pathway predicts major depressive disorder. Front. Psychiatr. 9, https:\/\/doi.org\/10.3389\/fpsyt.2018.00552.","DOI":"10.3389\/fpsyt.2018.00552"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_153","doi-asserted-by":"crossref","unstructured":"Lovelace, M.D., Varney, B., Sundaram, G., Franco, N.F., Ng, M.L., Pai, S., Lim, C.K., Guillemin, G.J., and Brew, B.J. (2016). Current evidence for a role of the kynurenine pathway of tryptophan metabolism in multiple sclerosis. Front. Immunol. 7, https:\/\/doi.org\/10.3389\/fimmu.2016.00246.","DOI":"10.3389\/fimmu.2016.00246"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_154","doi-asserted-by":"crossref","unstructured":"Lu, L., Neff, F., Fischer, D.A., Henze, C., Hirsch, E.C., Oertel, W.H., Schlegel, J., and Hartmann, A. (2006). Regional vulnerability of mesencephalic dopaminergic neurons prone to degenerate in Parkinson\u2019s disease: a post-mortem study in human control subjects. Neurobiol. Dis. 23: 409\u2013421, https:\/\/doi.org\/10.1016\/j.nbd.2006.04.002.","DOI":"10.1016\/j.nbd.2006.04.002"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_155","doi-asserted-by":"crossref","unstructured":"Luchowski, P., Luchowska, E., Turski, W.A., and Urbanska, E.M. (2002). 1-Methyl-4-phenylpyridinium and 3-nitropropionic acid diminish cortical synthesis of kynurenic acid via interference with kynurenine aminotransferases in rats. Neurosci. Lett. 330: 49\u201352, https:\/\/doi.org\/10.1016\/s0304-3940(02)00735-8.","DOI":"10.1016\/S0304-3940(02)00735-8"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_156","doi-asserted-by":"crossref","unstructured":"Luki\u0107, I., Ivkovi\u0107, S., Miti\u0107, M., and Ad\u017ei\u0107, M. (2022). Tryptophan metabolites in depression: modulation by gut microbiota. Front. Behav. Neurosci. 16: 987697, https:\/\/doi.org\/10.3389\/fnbeh.2022.987697.","DOI":"10.3389\/fnbeh.2022.987697"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_157","doi-asserted-by":"crossref","unstructured":"Marcial, G.E., Ford, A.L., Haller, M.J., Gezan, S.A., Harrison, N.A., Cai, D., Meyer, J.L., Perry, D.J., Atkinson, M.A., Wasserfall, C.H., et al.. (2017). Lactobacillus johnsonii N6.2 modulates the host immune responses: a double-blind, randomized trial in healthy adults. Front. Immunol. 8: 655, https:\/\/doi.org\/10.3389\/fimmu.2017.00655.","DOI":"10.3389\/fimmu.2017.00655"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_158","doi-asserted-by":"crossref","unstructured":"Marttila, S., Jylh\u00e4v\u00e4, J., Eklund, C., Hervonen, A., Jylh\u00e4, M., and Hurme, M. (2011). Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells. Immun. Ageing. 8: 9, https:\/\/doi.org\/10.1186\/1742-4933-8-9.","DOI":"10.1186\/1742-4933-8-9"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_159","doi-asserted-by":"crossref","unstructured":"Marx, W., McGuinness, A.J., Rocks, T., Ruusunen, A., Cleminson, J., Walker, A.J., Gomes-da-Costa, S., Lane, M., Sanches, M., Diaz, A.P., et al.. (2021). The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies. Mol. Psychiatr. 26: 4158\u20134178, https:\/\/doi.org\/10.1038\/s41380-020-00951-9.","DOI":"10.1038\/s41380-020-00951-9"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_160","doi-asserted-by":"crossref","unstructured":"Masuda, T., Sankowski, R., Staszewski, O., B\u00f6ttcher, C., Amann, L., Sagar, Scheiwe, C., Nessler, S., Kunz, P., van Loo, G., et al.. (2019). Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature 566: 388\u2013392, https:\/\/doi.org\/10.1038\/s41586-019-0924-x.","DOI":"10.1038\/s41586-019-0924-x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_161","doi-asserted-by":"crossref","unstructured":"Mathys, H., Davila-Velderrain, J., Peng, Z., Gao, F., Mohammadi, S., Young, J.Z., Menon, M., He, L., Abdurrob, F., Jiang, X., et al.. (2019). Single-cell transcriptomic analysis of Alzheimer\u2019s disease. Nature 570: 332\u2013337, https:\/\/doi.org\/10.1038\/s41586-019-1195-2.","DOI":"10.1038\/s41586-019-1195-2"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_162","doi-asserted-by":"crossref","unstructured":"Mazarei, G., Budac, D.P., Lu, G., Adomat, H., Tomlinson Guns, E.S., M\u00f6ller, T., and Leavitt, B.R. (2013a). Age-dependent alterations of the kynurenine pathway in the YAC128 mouse model of huntington disease. J.\u00a0Neurochem. 127: 852\u2013867, https:\/\/doi.org\/10.1111\/jnc.12350.","DOI":"10.1111\/jnc.12350"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_163","doi-asserted-by":"crossref","unstructured":"Mazarei, G., Budac, D.P., Lu, G., Lee, H., M\u00f6ller, T., and Leavitt, B.R. (2013b). The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain. Exp. Neurol. 249: 144\u2013148, https:\/\/doi.org\/10.1016\/j.expneurol.2013.08.007.","DOI":"10.1016\/j.expneurol.2013.08.007"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_164","doi-asserted-by":"crossref","unstructured":"McCaughey-Chapman, A. and Connor, B. (2022). Rat cortico-striatal sagittal organotypic slice cultures as ex\u00a0vivo excitotoxic striatal lesion models. Heliyon 8: e10819, https:\/\/doi.org\/10.1016\/j.heliyon.2022.e10819.","DOI":"10.1016\/j.heliyon.2022.e10819"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_165","doi-asserted-by":"crossref","unstructured":"McGeer, P.L., Itagaki, S., Boyes, B.E., and McGeer, E.G. (1988). Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson\u2019s and Alzheimer\u2019s disease brains. Neurology 38: 1285\u20131291, https:\/\/doi.org\/10.1212\/wnl.38.8.1285.","DOI":"10.1212\/WNL.38.8.1285"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_166","doi-asserted-by":"crossref","unstructured":"McQuade, A., Kang, Y.J., Hasselmann, J., Jairaman, A., Sotelo, A., Coburn, M., Shabestari, S.K., Chadarevian, J.P., Fote, G., Tu, C.H., et al.. (2020). Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u2019s disease. Nat. Commun. 11: 5370, https:\/\/doi.org\/10.1038\/s41467-020-19227-5.","DOI":"10.1038\/s41467-020-19227-5"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_167","doi-asserted-by":"crossref","unstructured":"Medzhitov, R. (2008). Origin and physiological roles of inflammation. Nature 454: 428\u2013435, https:\/\/doi.org\/10.1038\/nature07201.","DOI":"10.1038\/nature07201"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_168","doi-asserted-by":"crossref","unstructured":"Meilandt, W.J., Ngu, H., Gogineni, A., Lalehzadeh, G., Lee, S.H., Srinivasan, K., Imperio, J., Wu, T., Weber, M., Kruse, A.J., et al.. (2020). Trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the A\u03b242:A\u03b240 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. J.\u00a0Neurosci. 40: 1956\u20131974, https:\/\/doi.org\/10.1523\/jneurosci.1871-19.2019.","DOI":"10.1523\/JNEUROSCI.1871-19.2019"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_169","doi-asserted-by":"crossref","unstructured":"Mezrich, J.D., Fechner, J.H., Zhang, X., Johnson, B.P., Burlingham, W.J., and Bradfield, C.A. (2010). An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T\u00a0cells. J.\u00a0Immunol. 185: 3190\u20133198, https:\/\/doi.org\/10.4049\/jimmunol.0903670.","DOI":"10.4049\/jimmunol.0903670"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_170","doi-asserted-by":"crossref","unstructured":"Midttun, \u00d8., Ulvik, A., Meyer, K., Zahed, H., Giles, G.G., Manjer, J., Sandsveden, M., Langhammer, A., S\u00f8rgjerd, E.P., Behndig, A.F., et al.. (2023). A cross-sectional study of inflammatory markers as determinants of circulating kynurenines in the lung cancer cohort consortium. Sci. Rep. 13: 1011, https:\/\/doi.org\/10.1038\/s41598-023-28135-9.","DOI":"10.1038\/s41598-023-28135-9"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_171","doi-asserted-by":"crossref","unstructured":"Miller, C.L., Llenos, I.C., Dulay, J.R., and Weis, S. (2006). Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder. Brain Res. 1073\u20131074: 25\u201337, https:\/\/doi.org\/10.1016\/j.brainres.2005.12.056.","DOI":"10.1016\/j.brainres.2005.12.056"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_172","doi-asserted-by":"crossref","unstructured":"Miller, C.L., Llenos, I.C., Cwik, M., Walkup, J., and Weis, S. (2008). Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder. Neurochem. Int. 52: 1297\u20131303, https:\/\/doi.org\/10.1016\/j.neuint.2008.01.013.","DOI":"10.1016\/j.neuint.2008.01.013"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_173","doi-asserted-by":"crossref","unstructured":"Milnerwood, A.J., Gladding, C.M., Pouladi, M.A., Kaufman, A.M., Hines, R.M., Boyd, J.D., Ko, R.W., Vasuta, O.C., Graham, R.K., Hayden, M.R., et al.. (2010). Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington\u2019s disease mice. Neuron 65: 178\u2013190, https:\/\/doi.org\/10.1016\/j.neuron.2010.01.008.","DOI":"10.1016\/j.neuron.2010.01.008"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_174","doi-asserted-by":"crossref","unstructured":"Miranda, A.F., Boegman, R.J., Beninger, R.J., and Jhamandas, K. (1997). Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience 78: 967\u2013975, https:\/\/doi.org\/10.1016\/s0306-4522(96)00655-0.","DOI":"10.1016\/S0306-4522(96)00655-0"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_175","doi-asserted-by":"crossref","unstructured":"Monaghan, D.T. and Beaton, J.A. (1991). Quinolinate differentiates between forebrain and cerebellar NMDA receptors. Eur. J.\u00a0Pharmacol. 194: 123\u2013125, https:\/\/doi.org\/10.1016\/0014-2999(91)90134-c.","DOI":"10.1016\/0014-2999(91)90134-C"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_176","doi-asserted-by":"crossref","unstructured":"Murphy, N., Ramakrishnan, N., Vo-Le, B., Vo-Le, B., Smith, M.A., Iqbal, T., Swann, A.C., Mathew, S.J., and Lijffijt, M. (2021). A randomized cross-over trial to define neurophysiological correlates of AV-101 N-methyl-D-aspartate receptor blockade in healthy veterans. Neuropsychopharmacology 46: 820\u2013827, https:\/\/doi.org\/10.1038\/s41386-020-00917-z.","DOI":"10.1038\/s41386-020-00917-z"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_177","doi-asserted-by":"crossref","unstructured":"Nakanishi, S. (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258: 597\u2013603, https:\/\/doi.org\/10.1126\/science.1329206.","DOI":"10.1126\/science.1329206"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_178","doi-asserted-by":"crossref","unstructured":"Nathan, C. and Ding, A. (2010). Nonresolving inflammation. Cell 140: 871\u2013882, https:\/\/doi.org\/10.1016\/j.cell.2010.02.029.","DOI":"10.1016\/j.cell.2010.02.029"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_179","doi-asserted-by":"crossref","unstructured":"Needham, B.D., Funabashi, M., Adame, M.D., Wang, Z., Boktor, J.C., Haney, J., Wu, W.L., Rabut, C., Ladinsky, M.S., Hwang, S.J., et al.. (2022). A gut-derived metabolite alters brain activity and anxiety behaviour in mice. Nature 602: 647\u2013653, https:\/\/doi.org\/10.1038\/s41586-022-04396-8.","DOI":"10.1038\/s41586-022-04396-8"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_180","doi-asserted-by":"crossref","unstructured":"Nilsson, L.K., Linderholm, K.R., Engberg, G., Paulson, L., Blennow, K., Lindstr\u00f6m, L.H., Nordin, C., Karanti, A., Persson, P., and Erhardt, S. (2005). Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia. Schizophr. Res. 80: 315\u2013322, https:\/\/doi.org\/10.1016\/j.schres.2005.07.013.","DOI":"10.1016\/j.schres.2005.07.013"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_181","doi-asserted-by":"crossref","unstructured":"Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in\u00a0vivo. Science 308: 1314\u20131318, https:\/\/doi.org\/10.1126\/science.1110647.","DOI":"10.1126\/science.1110647"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_182","doi-asserted-by":"crossref","unstructured":"Ning, X.L., Li, Y.Z., Huo, C., Deng, J., Gao, C., Zhu, K.R., Wang, M., Wu, Y.X., Yu, J.L., Ren, Y.L., et al.. (2021). X-ray structure-guided discovery of a potent, orally bioavailable, dual human indoleamine\/Tryptophan 2,3-Dioxygenase (hIDO\/hTDO) inhibitor that shows activity in a mouse model of Parkinson\u2019s disease. J.\u00a0Med. Chem. 64: 8303\u20138332, https:\/\/doi.org\/10.1021\/acs.jmedchem.1c00303.","DOI":"10.1021\/acs.jmedchem.1c00303"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_183","doi-asserted-by":"crossref","unstructured":"O\u2019Connor, J.C., Andr\u00e9, C., Wang, Y., Lawson, M.A., Szegedi, S.S., Lestage, J., Castanon, N., Kelley, K.W., and Dantzer, R. (2009a). Interferon-gamma and tumor necrosis factor-alpha mediate the upregulation of indoleamine 2,3-dioxygenase and the induction of depressive-like behavior in mice in response to bacillus Calmette-Guerin. J.\u00a0Neurosci. 29: 4200\u20134209, https:\/\/doi.org\/10.1523\/jneurosci.5032-08.2009.","DOI":"10.1523\/JNEUROSCI.5032-08.2009"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_184","doi-asserted-by":"crossref","unstructured":"O\u2019Connor, J.C., Lawson, M.A., Andr\u00e9, C., Moreau, M., Lestage, J., Castanon, N., Kelley, K.W., and Dantzer, R. (2009b). Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol. Psychiatr. 14: 511\u2013522, https:\/\/doi.org\/10.1038\/sj.mp.4002148.","DOI":"10.1038\/sj.mp.4002148"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_185","doi-asserted-by":"crossref","unstructured":"O\u2019Farrell, K., Fagan, E., Connor, T.J., and Harkin, A. (2017). Inhibition of the kynurenine pathway protects against reactive microglial-associated reductions in the complexity of primary cortical neurons. Eur. J.\u00a0Pharmacol. 810: 163\u2013173, https:\/\/doi.org\/10.1016\/j.ejphar.2017.07.008.","DOI":"10.1016\/j.ejphar.2017.07.008"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_186","doi-asserted-by":"crossref","unstructured":"Obrenovitch, T.P. (2001). Quinolinic acid accumulation during neuroinflammation. Does it imply excitotoxicity? Ann. NY. Acad. Sci. 939: 1\u201310, https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03605.x.","DOI":"10.1111\/j.1749-6632.2001.tb03605.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_187","doi-asserted-by":"crossref","unstructured":"Ogawa, T., Matson, W.R., Beal, M.F., Myers, R.H., Bird, E.D., Milbury, P., and Saso, S. (1992). Kynurenine pathway abnormalities in Parkinson\u2019s disease. Neurology 42: 1702\u20131706, https:\/\/doi.org\/10.1212\/wnl.42.9.1702.","DOI":"10.1212\/WNL.42.9.1702"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_188","doi-asserted-by":"crossref","unstructured":"Ogawa, S., Fujii, T., Koga, N., Hori, H., Teraishi, T., Hattori, K., Noda, T., Higuchi, T., Motohashi, N., and Kunugi, H. (2014). Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis. J.\u00a0Clin. Psychiatr. 75: e906\u2013e915, https:\/\/doi.org\/10.4088\/jcp.13r08908.","DOI":"10.4088\/JCP.13r08908"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_189","doi-asserted-by":"crossref","unstructured":"Ogyu, K., Kubo, K., Noda, Y., Iwata, Y., Tsugawa, S., Omura, Y., Wada, M., Tarumi, R., Plitman, E., Moriguchi, S., et al.. (2018). Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci. Biobehav. Rev. 90: 16\u201325, https:\/\/doi.org\/10.1016\/j.neubiorev.2018.03.023.","DOI":"10.1016\/j.neubiorev.2018.03.023"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_190","doi-asserted-by":"crossref","unstructured":"Ohira, K., Hagihara, H., Toyama, K., Takao, K., Kanai, M., Funakoshi, H., Nakamura, T., and Miyakawa, T. (2010). Expression of tryptophan 2,3-dioxygenase in mature granule cells of the adult mouse dentate gyrus. Mol. Brain 3: 26, https:\/\/doi.org\/10.1186\/1756-6606-3-26.","DOI":"10.1186\/1756-6606-3-26"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_191","doi-asserted-by":"crossref","unstructured":"Okuda, S., Nishiyama, N., Saito, H., and Katsuki, H. (1998). 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J.\u00a0Neurochem. 70: 299\u2013307, https:\/\/doi.org\/10.1046\/j.1471-4159.1998.70010299.x.","DOI":"10.1046\/j.1471-4159.1998.70010299.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_192","doi-asserted-by":"crossref","unstructured":"Opitz, C.A., Litzenburger, U.M., Sahm, F., Ott, M., Tritschler, I., Trump, S., Schumacher, T., Jestaedt, L., Schrenk, D., Weller, M., et al.. (2011). An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478: 197\u2013203, https:\/\/doi.org\/10.1038\/nature10491.","DOI":"10.1038\/nature10491"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_193","doi-asserted-by":"crossref","unstructured":"Orhan, F., Bhat, M., Sandberg, K., St\u00e5hl, S., Piehl, F., consortium, K.S.P., Svensson, C., Erhardt, S., and Schwieler, L. (2016). Tryptophan metabolism along the kynurenine pathway downstream of toll-like receptor stimulation in peripheral monocytes. Scand. J.\u00a0Immunol. 84: 262\u2013271, https:\/\/doi.org\/10.1111\/sji.12479.","DOI":"10.1111\/sji.12479"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_194","doi-asserted-by":"crossref","unstructured":"Orhan, F., Schwieler, L., Engberg, G., and Samuelsson, M. (2024). Kynurenine metabolites in CSF and plasma in healthy males. Int. J.\u00a0Tryptophan. Res. 17: 11786469241245323, https:\/\/doi.org\/10.1177\/11786469241245323.","DOI":"10.1177\/11786469241245323"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_195","doi-asserted-by":"crossref","unstructured":"Ou, W., Chen, Y., Ju, Y., Ma, M., Qin, Y., Bi, Y., Liao, M., Liu, B., Liu, J., Zhang, Y., et al.. (2023). The kynurenine pathway in major depressive disorder under different disease states: a systematic review and meta-analysis. J.\u00a0Affect Disord. 339: 624\u2013632, https:\/\/doi.org\/10.1016\/j.jad.2023.07.078.","DOI":"10.1016\/j.jad.2023.07.078"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_196","unstructured":"Oxenkrug, G., van der Hart, M., Roeser, J., and Summergrad, P. (2016). Anthranilic acid: a potential biomarker and treatment target for schizophrenia. Ann. Psychiatr. Ment. Health 4: 1059."},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_197","doi-asserted-by":"crossref","unstructured":"Oxenkrug, G., van der Hart, M., Roeser, J., and Summergrad, P. (2017). Peripheral Tryptophan - kynurenine metabolism associated with metabolic syndrome is different in parkinson\u2019s and Alzheimer\u2019s diseases. Endocrinol. Diabetes Metab. J. 1: 1\u201310.","DOI":"10.31038\/EDMJ.2017141"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_198","doi-asserted-by":"crossref","unstructured":"Pallotta, M.T., Rossini, S., Suvieri, C., Coletti, A., Orabona, C., Macchiarulo, A., Volpi, C., and Grohmann, U. (2022). Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme. Febs. J. 289: 6099\u20136118, https:\/\/doi.org\/10.1111\/febs.16086.","DOI":"10.1111\/febs.16086"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_199","doi-asserted-by":"crossref","unstructured":"Paolicelli, R.C., Bolasco, G., Pagani, F., Maggi, L., Scianni, M., Panzanelli, P., Giustetto, M., Ferreira, T.A., Guiducci, E., Dumas, L., et al.. (2011). Synaptic pruning by microglia is necessary for normal brain development. Science 333: 1456\u20131458, https:\/\/doi.org\/10.1126\/science.1202529.","DOI":"10.1126\/science.1202529"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_200","doi-asserted-by":"crossref","unstructured":"Pardridge, W.M. and Fierer, G. (1990). Transport of tryptophan into brain from the circulating, albumin-bound pool in rats and in rabbits. J.\u00a0Neurochem. 54: 971\u2013976, https:\/\/doi.org\/10.1111\/j.1471-4159.1990.tb02345.x.","DOI":"10.1111\/j.1471-4159.1990.tb02345.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_201","doi-asserted-by":"crossref","unstructured":"Parkhurst, C.N., Yang, G., Ninan, I., Savas, J.N., Yates, J.R.3rd, Lafaille, J.J., Hempstead, B.L., Littman, D.R., and Gan, W.B. (2013). Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell 155: 1596\u20131609, https:\/\/doi.org\/10.1016\/j.cell.2013.11.030.","DOI":"10.1016\/j.cell.2013.11.030"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_202","doi-asserted-by":"crossref","unstructured":"Parrott, J.M., Redus, L., and O\u2019Connor, J.C. (2016). Kynurenine metabolic balance is disrupted in the hippocampus following peripheral lipopolysaccharide challenge. J.\u00a0Neuroinflammation 13: 124, https:\/\/doi.org\/10.1186\/s12974-016-0590-y.","DOI":"10.1186\/s12974-016-0590-y"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_203","doi-asserted-by":"crossref","unstructured":"Paul, E.R., Schwieler, L., Erhardt, S., Boda, S., Trepci, A., K\u00e4mpe, R., Asratian, A., Holm, L., Yngve, A., Dantzer, R., et al.. (2022). Peripheral and central kynurenine pathway abnormalities in major depression. Brain Behav. Immun. 101: 136\u2013145, https:\/\/doi.org\/10.1016\/j.bbi.2022.01.002.","DOI":"10.1016\/j.bbi.2022.01.002"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_204","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-De La Cruz, V., Gonz\u00e1lez-Cort\u00e9s, C., Galv\u00e1n-Arzate, S., Medina-Campos, O.N., P\u00e9rez-Severiano, F., Ali, S.F., Pedraza-Chaverr\u00ed, J., and Santamar\u00eda, A. (2005). Excitotoxic brain damage involves early peroxynitrite formation in a model of huntington\u2019s disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III). Neuroscience 135: 463\u2013474, https:\/\/doi.org\/10.1016\/j.neuroscience.2005.06.027.","DOI":"10.1016\/j.neuroscience.2005.06.027"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_205","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-De La Cruz, V., K\u00f6nigsberg, M., and Santamar\u00eda, A. (2007). Kynurenine pathway and disease: an overview. CNS Neurol. Disord. Drug Targets. 6: 398\u2013410, https:\/\/doi.org\/10.2174\/187152707783399229.","DOI":"10.2174\/187152707783399229"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_206","doi-asserted-by":"crossref","unstructured":"Perez-Pardo, P., Grobben, Y., Willemsen-Seegers, N., Hartog, M., Tutone, M., Muller, M., Adolfs, Y., Pasterkamp, R.J., Vu-Pham, D., van Doornmalen, A.M., et al. (2021). Pharmacological validation of TDO as a target for Parkinson\u2019s disease. Febs. J. 288: 4311\u20134331, https:\/\/doi.org\/10.1111\/febs.15721.","DOI":"10.1111\/febs.15721"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_207","doi-asserted-by":"crossref","unstructured":"Perkins, M.N. and Stone, T.W. (1982). An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid. Brain Res. 247: 184\u2013187, https:\/\/doi.org\/10.1016\/0006-8993(82)91048-4.","DOI":"10.1016\/0006-8993(82)91048-4"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_208","doi-asserted-by":"crossref","unstructured":"Peyton, L., Oliveros, A., Tufvesson-Alm, M., Schwieler, L., Starski, P., Engberg, G., Erhardt, S., and Choi, D.-S. (2019). Lipopolysaccharide increases cortical kynurenic acid and deficits in reference memory in mice. Int. J.\u00a0Tryptophan Res. 12: 1178646919891169, https:\/\/doi.org\/10.1177\/1178646919891169.","DOI":"10.1177\/1178646919891169"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_209","doi-asserted-by":"crossref","unstructured":"Pfefferkorn, E.R., Rebhun, S., and Eckel, M. (1986). Characterization of an indoleamine 2,3-dioxygenase induced by gamma-interferon in cultured human fibroblasts. J.\u00a0Interferon. Res. 6: 267\u2013279, https:\/\/doi.org\/10.1089\/jir.1986.6.267.","DOI":"10.1089\/jir.1986.6.267"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_210","doi-asserted-by":"crossref","unstructured":"Pienaar, L., Ramsamy, A., Millen, A.M.E., and Baijnath, S. (2025). Regional molecular changes in chronic lipopolysaccharide-induced neuroinflammation. Biol. Psychiatr. Global Open Sci. 5: 100515, https:\/\/doi.org\/10.1016\/j.bpsgos.2025.100515.","DOI":"10.1016\/j.bpsgos.2025.100515"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_211","doi-asserted-by":"crossref","unstructured":"Pierozan, P., Zamoner, A., Soska, A.K., Silvestrin, R.B., Loureiro, S.O., Heimfarth, L., Mello e Souza, T., Wajner, M., and Pessoa-Pureur, R. (2010). Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats. Exp. Neurol. 224: 188\u2013196, https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.009.","DOI":"10.1016\/j.expneurol.2010.03.009"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_212","doi-asserted-by":"crossref","unstructured":"Pierozan, P., Zamoner, A., Soska \u00c2, K., de Lima, B.O., Reis, K.P., Zamboni, F., Wajner, M., and Pessoa-Pureur, R. (2012). Signaling mechanisms downstream of quinolinic acid targeting the cytoskeleton of rat striatal neurons and astrocytes. Exp. Neurol. 233: 391\u2013399, https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.005.","DOI":"10.1016\/j.expneurol.2011.11.005"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_213","doi-asserted-by":"crossref","unstructured":"Pires, A.S., Sundaram, G., Heng, B., Krishnamurthy, S., Brew, B.J., and Guillemin, G.J. (2022). Recent advances in clinical trials targeting the kynurenine pathway. Pharmacol. Ther. 236: 108055, https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108055.","DOI":"10.1016\/j.pharmthera.2021.108055"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_214","doi-asserted-by":"crossref","unstructured":"Poliani, P.L., Wang, Y., Fontana, E., Robinette, M.L., Yamanishi, Y., Gilfillan, S., and Colonna, M. (2015). TREM2 sustains microglial expansion during aging and response to demyelination. J.\u00a0Clin. Invest. 125: 2161\u20132170, https:\/\/doi.org\/10.1172\/jci77983.","DOI":"10.1172\/JCI77983"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_215","doi-asserted-by":"crossref","unstructured":"Potter, M.C., Elmer, G.I., Bergeron, R., Albuquerque, E.X., Guidetti, P., Wu, H.Q., and Schwarcz, R. (2010). Reduction of endogenous kynurenic acid formation enhances extracellular glutamate, hippocampal plasticity, and cognitive behavior. Neuropsychopharmacology 35: 1734\u20131742, https:\/\/doi.org\/10.1038\/npp.2010.39.","DOI":"10.1038\/npp.2010.39"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_216","doi-asserted-by":"crossref","unstructured":"Puntel, R.L., Nogueira, C.W., and Rocha, J.B. (2005). N-methyl-D-aspartate receptors are involved in the quinolinic acid, but not in the malonate pro-oxidative activity in\u00a0vitro. Neurochem. Res. 30: 417\u2013424, https:\/\/doi.org\/10.1007\/s11064-005-2617-0.","DOI":"10.1007\/s11064-005-2617-0"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_217","doi-asserted-by":"crossref","unstructured":"Qin, W., Shi, Y., Chen, W., Jia, X., and Asakawa, T. (2022). Can kynurenine pathway be considered as a next-generation therapeutic target for Parkinson\u2019s disease? An update information. Biosci. Trends 16: 249\u2013256, https:\/\/doi.org\/10.5582\/bst.2022.01352.","DOI":"10.5582\/bst.2022.01352"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_218","doi-asserted-by":"crossref","unstructured":"Qiu, T., Guo, J., Wang, L., Shi, L., Ai, M., Xia, Z., Peng, Z., and Kuang, L. (2022). Dynamic microglial activation is associated with LPS-induced depressive-like behavior in mice: an [18F] DPA-714 PET imaging study. Bosn J.\u00a0Basic Med. Sci. 22: 649\u2013659, https:\/\/doi.org\/10.17305\/bjbms.2021.6825.","DOI":"10.17305\/bjbms.2021.6825"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_219","doi-asserted-by":"crossref","unstructured":"Rahman, A., Ting, K., Cullen, K.M., Braidy, N., Brew, B.J., and Guillemin, G.J. (2009). The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One 4: e6344, https:\/\/doi.org\/10.1371\/journal.pone.0006344.","DOI":"10.1371\/journal.pone.0006344"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_220","doi-asserted-by":"crossref","unstructured":"Rajmohan, R. and Reddy, P.H. (2017). Amyloid-beta and phosphorylated Tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons. J.\u00a0Alzheimers Dis. 57: 975\u2013999, https:\/\/doi.org\/10.3233\/jad-160612.","DOI":"10.3233\/JAD-160612"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_221","doi-asserted-by":"crossref","unstructured":"Rejdak, K., Bartosik-Psujek, H., Dobosz, B., Kocki, T., Grieb, P., Giovannoni, G., Turski, W.A., and Stelmasiak, Z. (2002). Decreased level of kynurenic acid in cerebrospinal fluid of relapsing-onset multiple sclerosis patients. Neurosci. Lett. 331: 63\u201365, https:\/\/doi.org\/10.1016\/s0304-3940(02)00710-3.","DOI":"10.1016\/S0304-3940(02)00710-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_222","doi-asserted-by":"crossref","unstructured":"Rossi, F., Schwarcz, R., and Rizzi, M. (2008). Curiosity to kill the KAT (kynurenine aminotransferase): structural insights into brain kynurenic acid synthesis. Curr. Opin. Struct. Biol. 18: 748\u2013755, https:\/\/doi.org\/10.1016\/j.sbi.2008.09.009.","DOI":"10.1016\/j.sbi.2008.09.009"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_223","doi-asserted-by":"crossref","unstructured":"Rothhammer, V., Mascanfroni, I.D., Bunse, L., Takenaka, M.C., Kenison, J.E., Mayo, L., Chao, C.C., Patel, B., Yan, R., Blain, M., et al.. (2016). Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22: 586\u2013597, https:\/\/doi.org\/10.1038\/nm.4106.","DOI":"10.1038\/nm.4106"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_224","doi-asserted-by":"crossref","unstructured":"Ruddick, J.P., Evans, A.K., Nutt, D.J., Lightman, S.L., Rook, G.A., and Lowry, C.A. (2006). Tryptophan metabolism in the central nervous system: medical implications. Expert. Rev. Mol. Med. 8: 1\u201327, https:\/\/doi.org\/10.1017\/s1462399406000068.","DOI":"10.1017\/S1462399406000068"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_225","doi-asserted-by":"crossref","unstructured":"Rudzki, L., Ostrowska, L., Pawlak, D., Ma\u0142us, A., Pawlak, K., Waszkiewicz, N., and Szulc, A. (2019). Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: a double-blind, randomized, placebo controlled study. Psychoneuroendocrinology 100: 213\u2013222, https:\/\/doi.org\/10.1016\/j.psyneuen.2018.10.010.","DOI":"10.1016\/j.psyneuen.2018.10.010"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_226","doi-asserted-by":"crossref","unstructured":"Saha, R.N. and Pahan, K. (2006). Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid. Redox Signal. 8: 929\u2013947, https:\/\/doi.org\/10.1089\/ars.2006.8.929.","DOI":"10.1089\/ars.2006.8.929"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_227","doi-asserted-by":"crossref","unstructured":"Salter, M., Hazelwood, R., Pogson, C.I., Iyer, R., Madge, D.J., Jones, H.T., Cooper, B.R., Cox, R.F., Wang, C.M., and Wiard, R.P. (1995). The effects of an inhibitor of tryptophan 2,3-dioxygenase and a combined inhibitor of tryptophan 2,3-dioxygenase and 5-HT reuptake in the rat. Neuropharmacology 34: 217\u2013227, https:\/\/doi.org\/10.1016\/0028-3908(94)00147-k.","DOI":"10.1016\/0028-3908(94)00147-K"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_228","doi-asserted-by":"crossref","unstructured":"Samavati, R., Z\u00e1dor, F., Sz\u0171cs, E., Tuka, B., Martos, D., Veres, G., G\u00e1sp\u00e1r, R., M\u00e1ndity, I.M., F\u00fcl\u00f6p, F., V\u00e9csei, L., et al.. (2017). Kynurenic acid and its analogue can alter the opioid receptor G-protein signaling after acute treatment via NMDA receptor in rat cortex and striatum. J.\u00a0Neurol. Sci. 376: 63\u201370, https:\/\/doi.org\/10.1016\/j.jns.2017.02.053.","DOI":"10.1016\/j.jns.2017.02.053"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_229","doi-asserted-by":"crossref","unstructured":"Sampson, T.R., Debelius, J.W., Thron, T., Janssen, S., Shastri, G.G., Ilhan, Z.E., Challis, C., Schretter, C.E., Rocha, S., Gradinaru, V., et al.. (2016). Gut Microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167: 1469\u20131480.e1412, https:\/\/doi.org\/10.1016\/j.cell.2016.11.018.","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_230","doi-asserted-by":"crossref","unstructured":"Santamar\u00eda, A., Galv\u00e1n-Arzate, S., Lis\u00fd, V., Ali, S.F., Duhart, H.M., Osorio-Rico, L., R\u00edos, C., and St\u2019astn\u00fd, F. (2001). Quinolinic acid induces oxidative stress in rat brain synaptosomes. Neuroreport 12: 871\u2013874, https:\/\/doi.org\/10.1097\/00001756-200103260-00049.","DOI":"10.1097\/00001756-200103260-00049"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_231","doi-asserted-by":"crossref","unstructured":"Sathyasaikumar, K.V., Stachowski, E.K., Wonodi, I., Roberts, R.C., Rassoulpour, A., McMahon, R.P., and Schwarcz, R. (2011). Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia. Schizophr. Bull. 37: 1147\u20131156, https:\/\/doi.org\/10.1093\/schbul\/sbq112.","DOI":"10.1093\/schbul\/sbq112"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_232","doi-asserted-by":"crossref","unstructured":"Sathyasaikumar, K.V., P\u00e9rez de la Cruz, V., Pineda, B., V\u00e1zquez Cervantes, G.I., Ram\u00edrez Ortega, D., Donley, D.W., Severson, P.L., West, B.L., Giorgini, F., Fox, J.H., et al.. (2022). Cellular localization of kynurenine 3-Monooxygenase in the brain: challenging the dogma. Antioxidants 11: 315, https:\/\/doi.org\/10.3390\/antiox11020315.","DOI":"10.3390\/antiox11020315"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_233","doi-asserted-by":"crossref","unstructured":"Savitz, J., Drevets, W.C., Wurfel, B.E., Ford, B.N., Bellgowan, P.S., Victor, T.A., Bodurka, J., Teague, T.K., and Dantzer, R. (2015). Reduction of kynurenic acid to quinolinic acid ratio in both the depressed and remitted phases of major depressive disorder. Brain Behav. Immun. 46: 55\u201359, https:\/\/doi.org\/10.1016\/j.bbi.2015.02.007.","DOI":"10.1016\/j.bbi.2015.02.007"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_234","doi-asserted-by":"crossref","unstructured":"Savitz, J. (2020). The kynurenine pathway: a finger in every pie. Mol. Psychiatr. 25: 131\u2013147, https:\/\/doi.org\/10.1038\/s41380-019-0414-4.","DOI":"10.1038\/s41380-019-0414-4"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_235","unstructured":"Schultz, S.H., North, S.W., and Shields, C.G. (2007). Schizophrenia: a review. Am. Fam. Phys. 75: 1821\u20131829."},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_236","doi-asserted-by":"crossref","unstructured":"Schwarcz, R. and K\u00f6hler, C. (1983). Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci. Lett. 38: 85\u201390, https:\/\/doi.org\/10.1016\/0304-3940(83)90115-5.","DOI":"10.1016\/0304-3940(83)90115-5"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_237","doi-asserted-by":"crossref","unstructured":"Schwarcz, R., Whetsell, W.O.Jr., and Mangano, R.M. (1983). Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain. Science 219: 316\u2013318, https:\/\/doi.org\/10.1126\/science.6849138.","DOI":"10.1126\/science.6849138"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_238","doi-asserted-by":"crossref","unstructured":"Schwarcz, R., Rassoulpour, A., Wu, H.Q., Medoff, D., Tamminga, C.A., and Roberts, R.C. (2001). Increased cortical kynurenate content in schizophrenia. Biol. Psychiatr. 50: 521\u2013530, https:\/\/doi.org\/10.1016\/s0006-3223(01)01078-2.","DOI":"10.1016\/S0006-3223(01)01078-2"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_239","doi-asserted-by":"crossref","unstructured":"Schwarcz, R., Bruno, J.P., Muchowski, P.J., and Wu, H.Q. (2012). Kynurenines in the mammalian brain: when physiology meets pathology. Nat. Rev. Neurosci. 13: 465\u2013477, https:\/\/doi.org\/10.1038\/nrn3257.","DOI":"10.1038\/nrn3257"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_240","doi-asserted-by":"crossref","unstructured":"Schwarcz, R. (2004). The kynurenine pathway of tryptophan degradation as a drug target. Curr. Opin. Pharmacol. 4: 12\u201317, https:\/\/doi.org\/10.1016\/j.coph.2003.10.006.","DOI":"10.1016\/j.coph.2003.10.006"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_241","doi-asserted-by":"crossref","unstructured":"Seifert, J. (1993). Assay of tryptophan 2,3-dioxygenase using liver slices and high-performance liquid chromatography. J.\u00a0Chromatogr. B: Biomed. Sci. Appl. 614: 227\u2013231, https:\/\/doi.org\/10.1016\/0378-4347(93)80313-s.","DOI":"10.1016\/0378-4347(93)80313-S"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_242","doi-asserted-by":"crossref","unstructured":"Shatova, O.P., Shestopalov, A.V., Zlatnik, E.Y., Novikova, I.A., Goncharova, A.S., and Maksimov, A.Y. (2025). The effect of fecal microbiota transplantation on levels of tryptophan metabolites in intestine and serum of gnotobiotic mice. Biomed. Khim. 71: 209\u2013216, https:\/\/doi.org\/10.18097\/pbmcr1554.","DOI":"10.18097\/PBMCR1554"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_243","doi-asserted-by":"crossref","unstructured":"Sheng, J.G., Mrak, R.E., and Griffin, W.S. (1994). S100 beta protein expression in Alzheimer disease: potential role in the pathogenesis of neuritic plaques. J.\u00a0Neurosci. Res. 39: 398\u2013404, https:\/\/doi.org\/10.1002\/jnr.490390406.","DOI":"10.1002\/jnr.490390406"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_244","doi-asserted-by":"crossref","unstructured":"Shi, B., Zhang, X., Song, Z., Dai, Z., Luo, K., Chen, B., Zhou, Z., Cui, Y., Feng, B., Zhu, Z., et al.. (2023). Targeting gut microbiota-derived kynurenine to predict and protect the remodeling of the pressure-overloaded young heart. Sci. Adv. 9: eadg7417, https:\/\/doi.org\/10.1126\/sciadv.adg7417.","DOI":"10.1126\/sciadv.adg7417"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_245","doi-asserted-by":"crossref","unstructured":"Silva-Islas, C.A., Santana-Mart\u00ednez, R.A., Le\u00f3n-Contreras, J.C., Barrera-Oviedo, D., Pedraza-Chaverri, J., Hern\u00e1ndez-Pando, R., and Maldonado, P.D. (2022). Quinolinic acid induces alterations in neuronal subcellular compartments, blocks autophagy Flux and activates necroptosis and apoptosis in rat striatum. Mol. Neurobiol. 59: 6632\u20136651, https:\/\/doi.org\/10.1007\/s12035-022-02986-1.","DOI":"10.1007\/s12035-022-02986-1"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_246","doi-asserted-by":"crossref","unstructured":"Sodhi, R.K., Bansal, Y., Singh, R., Saroj, P., Bhandari, R., Kumar, B., and Kuhad, A. (2021). IDO-1 inhibition protects against neuroinflammation, oxidative stress and mitochondrial dysfunction in 6-OHDA induced murine model of Parkinson\u2019s disease. Neurotoxicology 84: 184\u2013197, https:\/\/doi.org\/10.1016\/j.neuro.2021.03.009.","DOI":"10.1016\/j.neuro.2021.03.009"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_247","doi-asserted-by":"crossref","unstructured":"Sorgdrager, F.J.H., Vermeiren, Y., Van Faassen, M., van der Ley, C., Nollen, E.A.A., Kema, I.P., and De Deyn, P.P. (2019). Age- and disease-specific changes of the kynurenine pathway in Parkinson\u2019s and Alzheimer\u2019s disease. J.\u00a0Neurochem. 151: 656\u2013668, https:\/\/doi.org\/10.1111\/jnc.14843.","DOI":"10.1111\/jnc.14843"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_248","doi-asserted-by":"crossref","unstructured":"Sorgdrager, F., van Der Ley, C.P., van Faassen, M., Calus, E., Nollen, E.A., Kema, I.P., van Dam, D., and De Deyn, P.P. (2020). The effect of tryptophan 2,3-Dioxygenase inhibition on kynurenine metabolism and cognitive function in the APP23 mouse model of Alzheimer\u2019s disease. Int. J.\u00a0Tryptophan Res. 13: 1178646920972657, https:\/\/doi.org\/10.1177\/1178646920972657.","DOI":"10.1177\/1178646920972657"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_249","doi-asserted-by":"crossref","unstructured":"Sousa, R.D., Henriques, A.R., Caldas de Almeida, J., Canh\u00e3o, H., and Rodrigues, A.M. (2023). Unraveling depressive symptomatology and risk factors in a changing world. Int. J.\u00a0Environ. Res. Public Health 20, https:\/\/doi.org\/10.3390\/ijerph20166575.","DOI":"10.3390\/ijerph20166575"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_250","doi-asserted-by":"crossref","unstructured":"Souza, L.C., Jesse, C.R., Antunes, M.S., Ruff, J.R., de Oliveira Espinosa, D., Gomes, N.S., Donato, F., Giacomeli, R., and Boeira, S.P. (2016). Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-\u03b21-42 peptide in mice. Brain Behav. Immun. 56: 363\u2013377, https:\/\/doi.org\/10.1016\/j.bbi.2016.03.002.","DOI":"10.1016\/j.bbi.2016.03.002"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_251","doi-asserted-by":"crossref","unstructured":"St\u2019astn\u00fd, F., Skult\u00e9tyov\u00e1, I., Pliss, L., and Jezov\u00e1, D. (2000). Quinolinic acid enhances permeability of rat brain microvessels to plasma albumin. Brain Res. Bull. 53: 415\u2013420, https:\/\/doi.org\/10.1016\/s0361-9230(00)00368-3.","DOI":"10.1016\/S0361-9230(00)00368-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_252","doi-asserted-by":"crossref","unstructured":"St\u2019astn\u00fd, F., Lis\u00fd, V., Mares, V., Lis\u00e1, V., Balcar, V.J., and Santamar\u00eda, A. (2004). Quinolinic acid induces NMDA receptor-mediated lipid peroxidation in rat brain microvessels. Redox Rep. 9: 229\u2013233, https:\/\/doi.org\/10.1179\/135100004225006001.","DOI":"10.1179\/135100004225006001"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_253","doi-asserted-by":"crossref","unstructured":"Steiner, J., Walter, M., Gos, T., Guillemin, G.J., Bernstein, H.G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., Meyer zu Schwabedissen, L., et al.. (2011). Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission? J.\u00a0Neuroinflammation 8: 94, https:\/\/doi.org\/10.1186\/1742-2094-8-94.","DOI":"10.1186\/1742-2094-8-94"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_254","doi-asserted-by":"crossref","unstructured":"Stokholm, M.G., Iranzo, A., \u00d8stergaard, K., Serradell, M., Otto, M., Svendsen, K.B., Garrido, A., Vilas, D., Borghammer, P., Santamaria, J., et al.. (2017). Assessment of neuroinflammation in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a case-control study. Lancet Neurol. 16: 789\u2013796, https:\/\/doi.org\/10.1016\/S1474-4422(17)30173-4.","DOI":"10.1016\/S1474-4422(17)30173-4"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_255","doi-asserted-by":"crossref","unstructured":"Stone, T.W. and Perkins, M.N. (1981). Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J.\u00a0Pharmacol. 72: 411\u2013412, https:\/\/doi.org\/10.1016\/0014-2999(81)90587-2.","DOI":"10.1016\/0014-2999(81)90587-2"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_256","doi-asserted-by":"crossref","unstructured":"Stone, T.W. (1993). Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 45: 309\u2013379, https:\/\/doi.org\/10.1016\/s0031-6997(25)00441-7.","DOI":"10.1016\/S0031-6997(25)00441-7"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_257","doi-asserted-by":"crossref","unstructured":"Strasser, B., Berger, K., and Fuchs, D. (2015). Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults. Eur. J.\u00a0Nutr. 54: 101\u2013107, https:\/\/doi.org\/10.1007\/s00394-014-0690-3.","DOI":"10.1007\/s00394-014-0690-3"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_258","doi-asserted-by":"crossref","unstructured":"Sugisawa, E., Kondo, T., Kumagai, Y., Kato, H., Takayama, Y., Isohashi, K., Shimosegawa, E., Takemura, N., Hayashi, Y., Sasaki, T., et al.. (2022). Nociceptor-derived Reg3\u03b3 prevents endotoxic death by targeting kynurenine pathway in microglia. Cell Rep. 38: 110462, https:\/\/doi.org\/10.1016\/j.celrep.2022.110462.","DOI":"10.1016\/j.celrep.2022.110462"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_259","doi-asserted-by":"crossref","unstructured":"Sun, N., Hu, H., Wang, F., Li, L., Zhu, W., Shen, Y., Xiu, J., and Xu, Q. (2021). Antibiotic-induced microbiome depletion in adult mice disrupts blood-brain barrier and facilitates brain infiltration of monocytes after bone-marrow transplantation. Brain, Behav., and Immun. 92: 102\u2013114, https:\/\/doi.org\/10.1016\/j.bbi.2020.11.032.","DOI":"10.1016\/j.bbi.2020.11.032"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_260","doi-asserted-by":"crossref","unstructured":"Susel, Z., Engber, T.M., Kuo, S., and Chase, T.N. (1991). Prolonged infusion of quinolinic acid into rat striatum as an excitotoxic model of neurodegenerative disease. Neurosci. Lett. 121: 234\u2013238, https:\/\/doi.org\/10.1016\/0304-3940(91)90693-n.","DOI":"10.1016\/0304-3940(91)90693-N"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_261","doi-asserted-by":"crossref","unstructured":"Swartz, K.J., During, M.J., Freese, A., and Beal, M.F. (1990). Cerebral synthesis and release of kynurenic acid: an endogenous antagonist of excitatory amino acid receptors. J.\u00a0Neurosci. 10: 2965\u20132973, https:\/\/doi.org\/10.1523\/jneurosci.10-09-02965.1990.","DOI":"10.1523\/JNEUROSCI.10-09-02965.1990"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_262","doi-asserted-by":"crossref","unstructured":"Tabone, M., Bressa, C., Garc\u00eda-Merino, J.A., Moreno-P\u00e9rez, D., Van, E.C., Castelli, F.A., Fenaille, F., and Larrosa, M. (2021). The effect of acute moderate-intensity exercise on the serum and fecal metabolomes and the gut microbiota of cross-country endurance athletes. Sci. Rep. 11: 3558, https:\/\/doi.org\/10.1038\/s41598-021-82947-1.","DOI":"10.1038\/s41598-021-82947-1"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_263","doi-asserted-by":"crossref","unstructured":"Tandon, R., Nasrallah, H.A., and Keshavan, M.S. (2009). Schizophrenia, \u201cjust the facts\u201d 4. Clinical features and conceptualization. Schizophr. Res. 110: 1\u201323, https:\/\/doi.org\/10.1016\/j.schres.2009.03.005.","DOI":"10.1016\/j.schres.2009.03.005"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_264","doi-asserted-by":"crossref","unstructured":"Tashiro, T., Murakami, Y., Mouri, A., Imamura, Y., Nabeshima, T., Yamamoto, Y., and Saito, K. (2017). Kynurenine 3-monooxygenase is implicated in antidepressants-responsive depressive-like behaviors and monoaminergic dysfunctions. Behav. Brain Res. 317: 279\u2013285, https:\/\/doi.org\/10.1016\/j.bbr.2016.09.050.","DOI":"10.1016\/j.bbr.2016.09.050"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_265","doi-asserted-by":"crossref","unstructured":"Tavares, R.G., Tasca, C.I., Santos, C.E., Wajner, M., Souza, D.O., and Dutra-Filho, C.S. (2000). Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain. Neuroreport 11: 249\u2013253, https:\/\/doi.org\/10.1097\/00001756-200002070-00005.","DOI":"10.1097\/00001756-200002070-00005"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_266","doi-asserted-by":"crossref","unstructured":"Tavares, R.G., Tasca, C.I., Santos, C.E., Alves, L.B., Porci\u00fancula, L.O., Emanuelli, T., and Souza, D.O. (2002). Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem. Int. 40: 621\u2013627, https:\/\/doi.org\/10.1016\/s0197-0186(01)00133-4.","DOI":"10.1016\/S0197-0186(01)00133-4"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_267","doi-asserted-by":"crossref","unstructured":"Tavassoly, O., Sade, D., Bera, S., Shaham-Niv, S., Vocadlo, D.J., and Gazit, E. (2018). Quinolinic acid Amyloid-like fibrillar assemblies seed \u03b1-Synuclein aggregation. J.\u00a0Mol. Biol. 430: 3847\u20133862, https:\/\/doi.org\/10.1016\/j.jmb.2018.08.002.","DOI":"10.1016\/j.jmb.2018.08.002"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_268","doi-asserted-by":"crossref","unstructured":"Teraishi, T., Hori, H., Sasayama, D., Matsuo, J., Ogawa, S., Ota, M., Hattori, K., Kajiwara, M., Higuchi, T., and Kunugi, H. (2015). 13C-tryptophan breath test detects increased catabolic turnover of tryptophan along the kynurenine pathway in patients with major depressive disorder. Sci. Rep. 5: 15994, https:\/\/doi.org\/10.1038\/srep15994.","DOI":"10.1038\/srep15994"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_269","doi-asserted-by":"crossref","unstructured":"Terness, P., Bauer, T.M., R\u00f6se, L., Dufter, C., Watzlik, A., Simon, H., and Opelz, G. (2002). Inhibition of allogeneic T\u00a0cell proliferation by indoleamine 2,3-Dioxygenase\u2013expressing dendritic cells : mediation of suppression by tryptophan metabolites. J.\u00a0Exp. Med. 196: 447\u2013457, https:\/\/doi.org\/10.1084\/jem.20020052.","DOI":"10.1084\/jem.20020052"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_270","doi-asserted-by":"crossref","unstructured":"Th\u00e9ate, I., van Baren, N., Pilotte, L., Moulin, P., Larrieu, P., Renauld, J.-C., Herv\u00e9, C., Gutierrez-Roelens, I., Marbaix, E., Sempoux, C., et al. (2015). Extensive profiling of the expression of the indoleamine 2,3-Dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol. Res. 3: 161\u2013172, https:\/\/doi.org\/10.1158\/2326-6066.CIR-14-0137.","DOI":"10.1158\/2326-6066.CIR-14-0137"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_271","doi-asserted-by":"crossref","unstructured":"Thion, M.S., Low, D., Silvin, A., Chen, J., Grisel, P., Schulte-Schrepping, J., Blecher, R., Ulas, T., Squarzoni, P., Hoeffel, G., et al.. (2018). Microbiome influences prenatal and adult microglia in a sex-specific manner. Cell 172: 500-516.e516, https:\/\/doi.org\/10.1016\/j.cell.2017.11.042.","DOI":"10.1016\/j.cell.2017.11.042"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_272","doi-asserted-by":"crossref","unstructured":"Ting, K.K., Brew, B.J., and Guillemin, G.J. (2009). Effect of quinolinic acid on human astrocytes morphology and functions: implications in Alzheimer\u2019s disease. J.\u00a0Neuroinflammation 6: 36, https:\/\/doi.org\/10.1186\/1742-2094-6-36.","DOI":"10.1186\/1742-2094-6-36"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_273","doi-asserted-by":"crossref","unstructured":"Tsukahara, T., Hamouda, N., Utsumi, D., Matsumoto, K., Amagase, K., and Kato, S. (2017). G protein-coupled receptor 35 contributes to mucosal repair in mice via migration of colonic epithelial cells. Pharmacol. Res. 123: 27\u201339, https:\/\/doi.org\/10.1016\/j.phrs.2017.06.009.","DOI":"10.1016\/j.phrs.2017.06.009"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_274","doi-asserted-by":"crossref","unstructured":"van der Velpen, V., Teav, T., Gallart-Ayala, H., Mehl, F., Konz, I., Clark, C., Oikonomidi, A., Peyratout, G., Henry, H., Delorenzi, M., et al.. (2019). Systemic and central nervous system metabolic alterations in Alzheimer\u2019s disease. Alzheimers Res. Ther. 11: 93, https:\/\/doi.org\/10.1186\/s13195-019-0551-7.","DOI":"10.1186\/s13195-019-0551-7"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_275","doi-asserted-by":"crossref","unstructured":"Vazquez-Medina, A., Rodriguez-Trujillo, N., Ayuso-Rodriguez, K., Marini-Martinez, F., Angeli-Morales, R., Caussade-Silvestrini, G., Godoy-Vitorino, F., and Chorna, N. (2024). Exploring the interplay between running exercises, microbial diversity, and tryptophan metabolism along the microbiota-gut-brain axis. Front. Microbiol. 15: 1326584, https:\/\/doi.org\/10.3389\/fmicb.2024.1326584.","DOI":"10.3389\/fmicb.2024.1326584"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_276","doi-asserted-by":"crossref","unstructured":"Verdonk, F., Petit, A.C., Abdel-Ahad, P., Vinckier, F., Jouvion, G., de Maricourt, P., De Medeiros, G.F., Danckaert, A., Van Steenwinckel, J., Blatzer, M., et al.. (2019). Microglial production of quinolinic acid as a target and a biomarker of the antidepressant effect of ketamine. Brain Behav. Immun. 81: 361\u2013373, https:\/\/doi.org\/10.1016\/j.bbi.2019.06.033.","DOI":"10.1016\/j.bbi.2019.06.033"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_277","doi-asserted-by":"crossref","unstructured":"Vujkovic-Cvijin, I., Dunham, R.M., Iwai, S., Maher, M.C., Albright, R.G., Broadhurst, M.J., Hernandez, R.D., Lederman, M.M., Huang, Y., Somsouk, M., et al.. (2013). Dysbiosis of the gut microbiota is associated with HIV disease progression and tryptophan catabolism. Sci. Transl. Med. 5: 193ra191, https:\/\/doi.org\/10.1126\/scitranslmed.3006438.","DOI":"10.1126\/scitranslmed.3006438"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_278","doi-asserted-by":"crossref","unstructured":"Wake, H., Moorhouse, A.J., Jinno, S., Kohsaka, S., and Nabekura, J. (2009). Resting microglia directly monitor the functional state of synapses in\u00a0vivo and determine the fate of ischemic terminals. J.\u00a0Neurosci. 29: 3974\u20133980, https:\/\/doi.org\/10.1523\/jneurosci.4363-08.2009.","DOI":"10.1523\/JNEUROSCI.4363-08.2009"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_279","doi-asserted-by":"crossref","unstructured":"Walker, A.K., Wing, E.E., Banks, W.A., and Dantzer, R. (2019). Leucine competes with kynurenine for blood-to-brain transport and prevents lipopolysaccharide-induced depression-like behavior in mice. Mol. Psychiatr. 24: 1523\u20131532, https:\/\/doi.org\/10.1038\/s41380-018-0076-7.","DOI":"10.1038\/s41380-018-0076-7"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_280","doi-asserted-by":"crossref","unstructured":"Wallace, M., White, A., Grako, K.A., Lane, R., Cato, A.J., and Snodgrass, H.R. (2017). Randomized, double-blind, placebo-controlled, dose-escalation study: investigation of the safety, pharmacokinetics, and antihyperalgesic activity of l-4-chlorokynurenine in healthy volunteers. Scand J.\u00a0Pain 17: 243\u2013251, https:\/\/doi.org\/10.1016\/j.sjpain.2017.05.004.","DOI":"10.1016\/j.sjpain.2017.05.004"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_281","doi-asserted-by":"crossref","unstructured":"Wallen, Z.D., Demirkan, A., Twa, G., Cohen, G., Dean, M.N., Standaert, D.G., Sampson, T.R., and Payami, H. (2022). Metagenomics of Parkinson\u2019s disease implicates the gut microbiome in multiple disease mechanisms. Nat. Commun. 13: 6958, https:\/\/doi.org\/10.1038\/s41467-022-34667-x.","DOI":"10.1038\/s41467-022-34667-x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_282","doi-asserted-by":"crossref","unstructured":"Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J., Tian, H., and Ling, L. (2006). Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35. J.\u00a0Biol. Chem. 281: 22021\u201322028, https:\/\/doi.org\/10.1074\/jbc.m603503200.","DOI":"10.1074\/jbc.M603503200"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_283","doi-asserted-by":"crossref","unstructured":"Wang, Y., Lawson, M.A., Dantzer, R., and Kelley, K.W. (2010). LPS-induced indoleamine 2,3-dioxygenase is regulated in an interferon-\u03b3-independent manner by a JNK signaling pathway in primary murine microglia. Brain, Behav., Immun. 24: 201\u2013209, https:\/\/doi.org\/10.1016\/j.bbi.2009.06.152.","DOI":"10.1016\/j.bbi.2009.06.152"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_284","doi-asserted-by":"crossref","unstructured":"Wang, R., Zhao, S., Chen, X., Xiao, Z., Wen, X., Zhong, X., Li, S., Cheng, H., and Huang, G. (2022). Molecular mechanisms involved in the IL-6-mediated upregulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression in the chorionic villi and decidua of women in early pregnancy. BMC Pregnancy Childbirth 22: 983, https:\/\/doi.org\/10.1186\/s12884-022-05307-5.","DOI":"10.1186\/s12884-022-05307-5"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_285","doi-asserted-by":"crossref","unstructured":"Weber, M., Dietrich, D., Gr\u00e4sel, I., Reuter, G., Seifert, G., and Steinh\u00e4user, C. (2001). 6-Hydroxykynurenic acid and kynurenic acid differently antagonise AMPA and NMDA receptors in hippocampal neurones. J.\u00a0Neurochem. 77: 1108\u20131115, https:\/\/doi.org\/10.1046\/j.1471-4159.2001.00340.x.","DOI":"10.1046\/j.1471-4159.2001.00340.x"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_286","doi-asserted-by":"crossref","unstructured":"Weinberger, D.R. and Gallhofer, B. (1997). Cognitive function in schizophrenia. Int. Clin. Psychopharmacol. 12 (Suppl. 4): S29\u201336, https:\/\/doi.org\/10.1097\/00004850-199709004-00006.","DOI":"10.1097\/00004850-199709004-00006"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_287","doi-asserted-by":"crossref","unstructured":"Weller, M., Marini, A.M., Finiels-Marlier, F., Martin, B., and Paul, S.M. (1993). MK-801 and memantine protect cultured neurons from glutamate toxicity induced by glutamate carboxypeptidase-mediated cleavage of methotrexate. Eur. J.\u00a0Pharmacol.: Environ. Toxicol. Pharmacol. 248: 303\u2013312, https:\/\/doi.org\/10.1016\/0926-6917(93)90004-a.","DOI":"10.1016\/0926-6917(93)90004-A"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_288","doi-asserted-by":"crossref","unstructured":"Whiley, L., Chappell, K.E., D\u2019Hondt, E., Lewis, M.R., Jim\u00e9nez, B., Snowden, S.G., Soininen, H., K\u0142oszewska, I., Mecocci, P., Tsolaki, M., et al.. (2021). Metabolic phenotyping reveals a reduction in the bioavailability of serotonin and kynurenine pathway metabolites in both the urine and serum of individuals living with Alzheimer\u2019s disease. Alzheimer\u2019s Res. Ther. 13: 20, https:\/\/doi.org\/10.1186\/s13195-020-00741-z.","DOI":"10.1186\/s13195-020-00741-z"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_289","doi-asserted-by":"crossref","unstructured":"Widner, B., Leblhuber, F., Walli, J., Tilz, G.P., Demel, U., and Fuchs, D. (2000). Tryptophan degradation and immune activation in Alzheimer\u2019s disease. J.\u00a0Neural. Transm. (Vienna) 107: 343\u2013353, https:\/\/doi.org\/10.1007\/s007020050029.","DOI":"10.1007\/s007020050029"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_290","doi-asserted-by":"crossref","unstructured":"Widner, B., Leblhuber, F., and Fuchs, D. (2002). Increased neopterin production and tryptophan degradation in advanced Parkinson\u2019s disease. J.\u00a0Neural. Transm. (Vienna) 109: 181\u2013189, https:\/\/doi.org\/10.1007\/s007020200014.","DOI":"10.1007\/s007020200014"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_291","doi-asserted-by":"crossref","unstructured":"Wi\u0119d\u0142ocha, M., Marcinowicz, P., Janoska-Ja\u017adzik, M., and Szulc, A. (2021). Gut microbiota, kynurenine pathway and mental disorders - review. Prog. Neuropsychopharmacol. Biol. Psychiatr. 106: 110145, https:\/\/doi.org\/10.1016\/j.pnpbp.2020.110145.","DOI":"10.1016\/j.pnpbp.2020.110145"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_292","doi-asserted-by":"crossref","unstructured":"Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., and Siuzdak, G. (2009). Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc. Natl. Acad. Sci. USA 106: 3698\u20133703, https:\/\/doi.org\/10.1073\/pnas.0812874106.","DOI":"10.1073\/pnas.0812874106"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_293","doi-asserted-by":"crossref","unstructured":"Willette, A.A., Pappas, C., Hoth, N., Wang, Q., Klinedinst, B., Willette, S.A., Larsen, B., Pollpeter, A., Li, T., Le, S., et al.. (2021). Inflammation, negative affect, and amyloid burden in Alzheimer\u2019s disease: insights from the kynurenine pathway. Brain Behav. Immun. 95: 216\u2013225, https:\/\/doi.org\/10.1016\/j.bbi.2021.03.019.","DOI":"10.1016\/j.bbi.2021.03.019"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_294","doi-asserted-by":"crossref","unstructured":"Wu, H.Q., Salituro, F.G., and Schwarcz, R. (1997). Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in\u00a0vivo. Eur. J.\u00a0Pharmacol. 319: 13\u201320, https:\/\/doi.org\/10.1016\/s0014-2999(96)00829-1.","DOI":"10.1016\/S0014-2999(96)00829-1"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_295","doi-asserted-by":"crossref","unstructured":"Wu, H.Q., Lee, S.C., and Schwarcz, R. (2000). Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus. Eur. J.\u00a0Pharmacol. 390: 267\u2013274, https:\/\/doi.org\/10.1016\/s0014-2999(00)00024-8.","DOI":"10.1016\/S0014-2999(00)00024-8"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_296","doi-asserted-by":"crossref","unstructured":"Wu, H.Q., Rassoulpour, A., and Schwarcz, R. (2002). Effect of systemic L-DOPA administration on extracellular kynurenate levels in the rat striatum. J.\u00a0Neural. Transm. (Vienna) 109: 239\u2013249, https:\/\/doi.org\/10.1007\/s007020200020.","DOI":"10.1007\/s007020200020"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_297","doi-asserted-by":"crossref","unstructured":"Xiao, L., Yan, J., Yang, T., Zhu, J., Li, T., Wei, H., and Chen, J. (2021). Fecal microbiome transplantation from children with autism spectrum disorder modulates tryptophan and serotonergic synapse metabolism and induces altered behaviors in germ-free mice. mSystems 6: e01343-20, https:\/\/doi.org\/10.1128\/msystems.01343-20.","DOI":"10.1128\/msystems.01343-20"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_298","doi-asserted-by":"crossref","unstructured":"Xu, J., Huang, Y., Wei, L., Kong, Z., Fu, J., and Cai, L. (2025). KMO inhibition improves seizures and depressive-like behaviors without aggravating cognitive impairment in epileptic mice. Curr. Issues. Mol. Biol. 47: 705, https:\/\/doi.org\/10.3390\/cimb47090705.","DOI":"10.3390\/cimb47090705"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_299","doi-asserted-by":"crossref","unstructured":"Yadav, M.C., Burudi, E.M.E., Alirezaei, M., Flynn, C.C., Watry, D.D., Lanigan, C.M., and Fox, H.S. (2007). IFN-\u03b3-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia 55: 1385\u20131396, https:\/\/doi.org\/10.1002\/glia.20544.","DOI":"10.1002\/glia.20544"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_300","doi-asserted-by":"crossref","unstructured":"Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., Nagler, C.R., Ismagilov, R.F., Mazmanian, S.K., and Hsiao, E.Y. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161: 264\u2013276, https:\/\/doi.org\/10.1016\/j.cell.2015.02.047.","DOI":"10.1016\/j.cell.2015.02.047"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_301","doi-asserted-by":"crossref","unstructured":"Yao, K. and Zhao, Y.F. (2018). Aging modulates microglia phenotypes in neuroinflammation of MPTP-PD mice. Exp. Gerontol. 111: 86\u201393, https:\/\/doi.org\/10.1016\/j.exger.2018.07.010.","DOI":"10.1016\/j.exger.2018.07.010"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_302","doi-asserted-by":"crossref","unstructured":"Yao, J.K., Dougherty, G.G.Jr., Reddy, R.D., Keshavan, M.S., Montrose, D.M., Matson, W.R., Rozen, S., Krishnan, R.R., McEvoy, J., and Kaddurah-Daouk, R. (2010). Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia. Mol. Psychiatr. 15: 938\u2013953, https:\/\/doi.org\/10.1038\/mp.2009.33.","DOI":"10.1038\/mp.2009.33"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_303","doi-asserted-by":"crossref","unstructured":"Youn, H.-S., Kim, T.G., Kim, M.-K., Kang, G.B., Kang, J.Y., Lee, J.-G., An, J.Y., Park, K.R., Lee, Y.j., Im, Y.J., et al.. (2016). Structural Insights into the Quaternary Catalytic Mechanism of Hexameric Human Quinolinate Phosphoribosyltransferase, a Key Enzyme in de novo NAD Biosynthesis. Sci. Rep. 6: 19681, https:\/\/doi.org\/10.1038\/srep19681.","DOI":"10.1038\/srep19681"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_304","doi-asserted-by":"crossref","unstructured":"Yu, P., Li, Z., Zhang, L., Tagle, D.A., and Cai, T. (2006). Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family. Gene 365: 111\u2013118, https:\/\/doi.org\/10.1016\/j.gene.2005.09.034.","DOI":"10.1016\/j.gene.2005.09.034"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_305","doi-asserted-by":"crossref","unstructured":"Yu, D., Tao, B.B., Yang, Y.Y., Du, L.S., Yang, S.S., He, X.J., Zhu, Y.W., Yan, J.K., and Yang, Q. (2015). The IDO inhibitor coptisine ameliorates cognitive impairment in a mouse model of Alzheimer\u2019s disease. J.\u00a0Alzheimers Dis. 43: 291\u2013302, https:\/\/doi.org\/10.3233\/jad-140414.","DOI":"10.3233\/JAD-140414"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_306","doi-asserted-by":"crossref","unstructured":"\u017barnowska, I., Wr\u00f3bel-Dudzi\u0144ska, D., Tulidowicz-Bielak, M., Kocki, T., Mitosek-Szewczyk, K., Gasior, M., and Turski, W.A. (2019). Changes in tryptophan and kynurenine pathway metabolites in the blood of children treated with ketogenic diet for refractory epilepsy. Seizure 69: 265\u2013272, https:\/\/doi.org\/10.1016\/j.seizure.2019.05.006.","DOI":"10.1016\/j.seizure.2019.05.006"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_307","doi-asserted-by":"crossref","unstructured":"Zhang, W., Xiao, D., Mao, Q., and Xia, H. (2023). Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target. Ther. 8: 267, https:\/\/doi.org\/10.1038\/s41392-023-01486-5.","DOI":"10.1038\/s41392-023-01486-5"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_308","doi-asserted-by":"crossref","unstructured":"Zhao, L.P., Wu, J., Quan, W., Zhou, Y., Hong, H., Niu, G.Y., Li, T., Huang, S.B., Qiao, C.M., Zhao, W.J., et al.. (2022). DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota. Front. Immunol. 13: 1089200, https:\/\/doi.org\/10.3389\/fimmu.2022.1089200.","DOI":"10.3389\/fimmu.2022.1089200"},{"key":"2026060415053182102_j_revneuro-2025-0130_ref_309","doi-asserted-by":"crossref","unstructured":"Zwilling, D., Huang, S.Y., Sathyasaikumar, K.V., Notarangelo, F.M., Guidetti, P., Wu, H.Q., Lee, J., Truong, J., Andrews-Zwilling, Y., Hsieh, E.W., et al.. (2011). Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration. Cell 145: 863\u2013874, https:\/\/doi.org\/10.1016\/j.cell.2011.05.020.","DOI":"10.1016\/j.cell.2011.05.020"}],"container-title":["Reviews in the Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0130\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0130\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:08:47Z","timestamp":1780585727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/revneuro-2025-0130\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":309,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,3,10]]},"published-print":{"date-parts":[[2026,6,24]]}},"alternative-id":["10.1515\/revneuro-2025-0130"],"URL":"https:\/\/doi.org\/10.1515\/revneuro-2025-0130","relation":{},"ISSN":["0334-1763","2191-0200"],"issn-type":[{"value":"0334-1763","type":"print"},{"value":"2191-0200","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]}}}